Encounter Well child visit (procedure) 05-11-1966
Condition Risk activity involvement (finding) 05-11-1966
Encounter General examination of patient (procedure) 05-28-1969
Condition Received higher education (finding) 05-28-1969
Encounter General examination of patient (procedure) 06-06-1973
Condition Essential hypertension (disorder) 06-06-1973
Encounter Prenatal initial visit 09-05-2001
Condition Miscarriage in first trimester 09-05-2001
Encounter General examination of patient (procedure) 12-01-2004
Condition Chronic kidney disease stage 1 (disorder) 12-01-2004
Condition Disorder of kidney due to diabetes mellitus (disorder) 12-01-2004
Encounter General examination of patient (procedure) 12-07-2005
Condition Chronic kidney disease stage 2 (disorder) 12-07-2005
Condition Microalbuminuria due to type 2 diabetes mellitus (disorder) 12-07-2005
Encounter Encounter for check up (procedure) 07-25-2012
Encounter Encounter for check up (procedure) 09-26-2012
Encounter General examination of patient (procedure) 01-16-2013
Encounter Encounter for check up (procedure) 06-26-2013
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 06-26-2013
Encounter General examination of patient (procedure) 01-22-2014
Condition Ischemic heart disease (disorder) 01-22-2014
Observation Glucose [Mass/volume] in Serum or Plasma 01-22-2014 89.43 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 01-22-2014 16.41 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 01-22-2014 2.0373 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 01-22-2014 9.41 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 01-22-2014 138.83 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 01-22-2014 4.92 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 01-22-2014 104.56 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 01-22-2014 21.17 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 01-22-2014 81.482 mL/min/{1.73_m2}
Observation Appearance of Urine 01-22-2014
Observation Odor of Urine 01-22-2014
Observation Clarity of Urine 01-22-2014
Observation Color of Urine 01-22-2014
Observation Glucose [Mass/volume] in Urine by Test strip 01-22-2014 0.89372 mg/dL
Observation Glucose [Presence] in Urine by Test strip 01-22-2014
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 01-22-2014 0.84706 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 01-22-2014
Observation Ketones [Mass/volume] in Urine by Test strip 01-22-2014 15.524 mg/dL
Observation Ketones [Presence] in Urine by Test strip 01-22-2014
Observation Specific gravity of Urine by Test strip 01-22-2014 1.0046 {nominal}
Observation pH of Urine by Test strip 01-22-2014 5.2411 pH
Observation Protein [Mass/volume] in Urine by Test strip 01-22-2014 247.6 mg/dL
Observation Protein [Presence] in Urine by Test strip 01-22-2014
Observation Nitrite [Presence] in Urine by Test strip 01-22-2014
Observation Hemoglobin [Presence] in Urine by Test strip 01-22-2014
Observation Leukocyte esterase [Presence] in Urine by Test strip 01-22-2014
Observation Body Height 01-22-2014 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 01-22-2014 3 {score}
Observation Body Weight 01-22-2014 82.2 kg
Observation Body mass index (BMI) [Ratio] 01-22-2014 27.34 kg/m2
Observation Blood pressure panel with all children optional 01-22-2014
Observation Heart rate 01-22-2014 76 /min
Observation Respiratory rate 01-22-2014 13 /min
Observation Leukocytes [#/volume] in Blood by Automated count 01-22-2014 4.0359 10*3/uL
Observation Erythrocytes [#/volume] in Blood by Automated count 01-22-2014 4.7272 10*6/uL
Observation Hemoglobin [Mass/volume] in Blood 01-22-2014 15.558 g/dL
Observation Hematocrit [Volume Fraction] of Blood by Automated count 01-22-2014 42.33 %
Observation MCV [Entitic volume] by Automated count 01-22-2014 86.536 fL
Observation MCH [Entitic mass] by Automated count 01-22-2014 27.563 pg
Observation MCHC [Mass/volume] by Automated count 01-22-2014 35.584 g/dL
Observation Erythrocyte distribution width [Entitic volume] by Automated count 01-22-2014 44.769 fL
Observation Platelets [#/volume] in Blood by Automated count 01-22-2014 392.52 10*3/uL
Observation Platelet distribution width [Entitic volume] in Blood by Automated count 01-22-2014 308.55 fL
Observation Platelet mean volume [Entitic volume] in Blood by Automated count 01-22-2014 9.9583 fL
Observation Tobacco smoking status 01-22-2014
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 01-22-2014
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 01-22-2014 6 {score}
Observation Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 01-22-2014 26 {score}
Procedure Medication Reconciliation (procedure) 01-22-2014
Procedure Assessment of health and social care needs (procedure) 01-22-2014
Procedure Depression screening (procedure) 01-22-2014
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 01-22-2014
Procedure Depression screening using Patient Health Questionnaire Nine Item score (procedure) 01-22-2014
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 01-22-2014
MedicationRequest Clopidogrel 75 MG Oral Tablet 01-29-2014
MedicationRequest Simvastatin 20 MG Oral Tablet 01-29-2014
MedicationRequest 24 HR metoprolol succinate 100 MG Extended Release Oral Tablet 01-29-2014
MedicationRequest Nitroglycerin 0.4 MG/ACTUAT Mucosal Spray 01-29-2014
Immunization Influenza, seasonal, injectable, preservative free 01-22-2014
Encounter Encounter for problem (procedure) 02-05-2014
Observation Operative Status 02-05-2014
Procedure Referral to cardiology service (procedure) 02-05-2014
Encounter Encounter for problem (procedure) 02-11-2014
Condition Abnormal findings diagnostic imaging heart+coronary circulat (finding) 02-11-2014
Procedure Consultation for treatment (procedure) 02-11-2014
Procedure Angiography of coronary artery (procedure) 02-11-2014
Procedure Post anesthesia care management (procedure) 02-11-2014
Procedure Referral to cardiology service (procedure) 02-11-2014
Encounter Encounter for check up (procedure) 02-19-2014
Observation Glucose [Mass/volume] in Serum or Plasma 02-19-2014 94.08 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 02-19-2014 14.04 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 02-19-2014 1.8171 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 02-19-2014 9.35 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 02-19-2014 139.17 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 02-19-2014 4.57 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 02-19-2014 103.5 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 02-19-2014 25.51 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 02-19-2014 79.355 mL/min/{1.73_m2}
Observation Appearance of Urine 02-19-2014
Observation Odor of Urine 02-19-2014
Observation Clarity of Urine 02-19-2014
Observation Color of Urine 02-19-2014
Observation Glucose [Mass/volume] in Urine by Test strip 02-19-2014 1.0896 mg/dL
Observation Glucose [Presence] in Urine by Test strip 02-19-2014
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 02-19-2014 1.4458 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 02-19-2014
Observation Ketones [Mass/volume] in Urine by Test strip 02-19-2014 14.903 mg/dL
Observation Ketones [Presence] in Urine by Test strip 02-19-2014
Observation Specific gravity of Urine by Test strip 02-19-2014 1.0339 {nominal}
Observation pH of Urine by Test strip 02-19-2014 6.6471 pH
Observation Protein [Mass/volume] in Urine by Test strip 02-19-2014 303.75 mg/dL
Observation Protein [Presence] in Urine by Test strip 02-19-2014
Observation Nitrite [Presence] in Urine by Test strip 02-19-2014
Observation Hemoglobin [Presence] in Urine by Test strip 02-19-2014
Observation Leukocyte esterase [Presence] in Urine by Test strip 02-19-2014
Observation Body Height 02-19-2014 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 02-19-2014 3 {score}
Observation Body Weight 02-19-2014 82.2 kg
Observation Body mass index (BMI) [Ratio] 02-19-2014 27.34 kg/m2
Observation Blood pressure panel with all children optional 02-19-2014
Observation Heart rate 02-19-2014 63 /min
Observation Respiratory rate 02-19-2014 13 /min
Observation Tobacco smoking status 02-19-2014
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 02-19-2014
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 02-19-2014 0 {score}
Observation Total score [DAST-10] 02-19-2014 1 {score}
Procedure Assessment of health and social care needs (procedure) 02-19-2014
Procedure Depression screening (procedure) 02-19-2014
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 02-19-2014
Procedure Assessment of substance use (procedure) 02-19-2014
Procedure Screening for drug abuse (procedure) 02-19-2014
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 02-19-2014
Encounter Encounter for problem (procedure) 02-26-2014
Procedure Percutaneous coronary intervention (procedure) 02-26-2014
Encounter General examination of patient (procedure) 01-28-2015
Observation Glucose [Mass/volume] in Serum or Plasma 01-28-2015 79.41 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 01-28-2015 8.18 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 01-28-2015 1.8819 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 01-28-2015 9.97 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 01-28-2015 137.54 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 01-28-2015 4.3 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 01-28-2015 101.2 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 01-28-2015 27.02 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 01-28-2015 73.237 mL/min/{1.73_m2}
Observation Appearance of Urine 01-28-2015
Observation Odor of Urine 01-28-2015
Observation Clarity of Urine 01-28-2015
Observation Color of Urine 01-28-2015
Observation Glucose [Mass/volume] in Urine by Test strip 01-28-2015 0.98828 mg/dL
Observation Glucose [Presence] in Urine by Test strip 01-28-2015
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 01-28-2015 0.23262 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 01-28-2015
Observation Ketones [Mass/volume] in Urine by Test strip 01-28-2015 0.045651 mg/dL
Observation Ketones [Presence] in Urine by Test strip 01-28-2015
Observation Specific gravity of Urine by Test strip 01-28-2015 1.0249 {nominal}
Observation pH of Urine by Test strip 01-28-2015 6.4327 pH
Observation Protein [Mass/volume] in Urine by Test strip 01-28-2015 159.24 mg/dL
Observation Protein [Presence] in Urine by Test strip 01-28-2015
Observation Nitrite [Presence] in Urine by Test strip 01-28-2015
Observation Hemoglobin [Presence] in Urine by Test strip 01-28-2015
Observation Leukocyte esterase [Presence] in Urine by Test strip 01-28-2015
Observation Body Height 01-28-2015 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 01-28-2015 3 {score}
Observation Body Weight 01-28-2015 82.2 kg
Observation Body mass index (BMI) [Ratio] 01-28-2015 27.34 kg/m2
Observation Blood pressure panel with all children optional 01-28-2015
Observation Heart rate 01-28-2015 62 /min
Observation Respiratory rate 01-28-2015 16 /min
Observation Cholesterol [Mass/volume] in Serum or Plasma 01-28-2015 174.14 mg/dL
Observation Triglycerides 01-28-2015 108.27 mg/dL
Observation Low Density Lipoprotein Cholesterol 01-28-2015 102.82 mg/dL
Observation Cholesterol in HDL [Mass/volume] in Serum or Plasma 01-28-2015 49.67 mg/dL
Observation Tobacco smoking status 01-28-2015
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 01-28-2015
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 01-28-2015 3 {score}
Observation Total score [DAST-10] 01-28-2015 2 {score}
Procedure Assessment of health and social care needs (procedure) 01-28-2015
Procedure Assessment of anxiety (procedure) 01-28-2015
Procedure Assessment of substance use (procedure) 01-28-2015
Procedure Screening for drug abuse (procedure) 01-28-2015
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 01-28-2015
Immunization Influenza, seasonal, injectable, preservative free 01-28-2015
Encounter Encounter for check up (procedure) 04-15-2015
Observation Glucose [Mass/volume] in Serum or Plasma 04-15-2015 72.41 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 04-15-2015 13.82 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 04-15-2015 1.8279 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 04-15-2015 9.71 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 04-15-2015 140.75 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 04-15-2015 3.94 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 04-15-2015 106.57 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 04-15-2015 26.2 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 04-15-2015 69.313 mL/min/{1.73_m2}
Observation Appearance of Urine 04-15-2015
Observation Odor of Urine 04-15-2015
Observation Clarity of Urine 04-15-2015
Observation Color of Urine 04-15-2015
Observation Glucose [Mass/volume] in Urine by Test strip 04-15-2015 1.8605 mg/dL
Observation Glucose [Presence] in Urine by Test strip 04-15-2015
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 04-15-2015 1.2178 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 04-15-2015
Observation Ketones [Mass/volume] in Urine by Test strip 04-15-2015 9.4256 mg/dL
Observation Ketones [Presence] in Urine by Test strip 04-15-2015
Observation Specific gravity of Urine by Test strip 04-15-2015 1.034 {nominal}
Observation pH of Urine by Test strip 04-15-2015 6.0955 pH
Observation Protein [Mass/volume] in Urine by Test strip 04-15-2015 259.28 mg/dL
Observation Protein [Presence] in Urine by Test strip 04-15-2015
Observation Nitrite [Presence] in Urine by Test strip 04-15-2015
Observation Hemoglobin [Presence] in Urine by Test strip 04-15-2015
Observation Leukocyte esterase [Presence] in Urine by Test strip 04-15-2015
Observation Body Height 04-15-2015 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 04-15-2015 4 {score}
Observation Body Weight 04-15-2015 82.2 kg
Observation Body mass index (BMI) [Ratio] 04-15-2015 27.34 kg/m2
Observation Blood pressure panel with all children optional 04-15-2015
Observation Heart rate 04-15-2015 75 /min
Observation Respiratory rate 04-15-2015 14 /min
Observation Tobacco smoking status 04-15-2015
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 04-15-2015
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 04-15-2015 1 {score}
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 04-15-2015 1 {score}
Observation Total score [AUDIT-C] 04-15-2015 2 {score}
Procedure Assessment of health and social care needs (procedure) 04-15-2015
Procedure Assessment of anxiety (procedure) 04-15-2015
Procedure Depression screening (procedure) 04-15-2015
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 04-15-2015
Procedure Assessment of substance use (procedure) 04-15-2015
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 04-15-2015
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 04-15-2015
Encounter Encounter for check up (procedure) 11-11-2015
Observation Glucose [Mass/volume] in Serum or Plasma 11-11-2015 79.22 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 11-11-2015 19.5 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 11-11-2015 1.8626 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 11-11-2015 9.54 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 11-11-2015 139.71 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 11-11-2015 3.98 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 11-11-2015 109.39 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 11-11-2015 23.97 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 11-11-2015 73.812 mL/min/{1.73_m2}
Observation Appearance of Urine 11-11-2015
Observation Odor of Urine 11-11-2015
Observation Clarity of Urine 11-11-2015
Observation Color of Urine 11-11-2015
Observation Glucose [Mass/volume] in Urine by Test strip 11-11-2015 2.2524 mg/dL
Observation Glucose [Presence] in Urine by Test strip 11-11-2015
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 11-11-2015 0.52306 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 11-11-2015
Observation Ketones [Mass/volume] in Urine by Test strip 11-11-2015 9.973 mg/dL
Observation Ketones [Presence] in Urine by Test strip 11-11-2015
Observation Specific gravity of Urine by Test strip 11-11-2015 1.0275 {nominal}
Observation pH of Urine by Test strip 11-11-2015 6.7451 pH
Observation Protein [Mass/volume] in Urine by Test strip 11-11-2015 212.97 mg/dL
Observation Protein [Presence] in Urine by Test strip 11-11-2015
Observation Nitrite [Presence] in Urine by Test strip 11-11-2015
Observation Hemoglobin [Presence] in Urine by Test strip 11-11-2015
Observation Leukocyte esterase [Presence] in Urine by Test strip 11-11-2015
Observation Body Height 11-11-2015 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 11-11-2015 1 {score}
Observation Body Weight 11-11-2015 82.2 kg
Observation Body mass index (BMI) [Ratio] 11-11-2015 27.34 kg/m2
Observation Blood pressure panel with all children optional 11-11-2015
Observation Heart rate 11-11-2015 84 /min
Observation Respiratory rate 11-11-2015 14 /min
Observation Tobacco smoking status 11-11-2015
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 11-11-2015
Observation Total score [HARK] 11-11-2015 0 {score}
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 11-11-2015 2 {score}
Observation Total score [DAST-10] 11-11-2015 1 {score}
Procedure Medication Reconciliation (procedure) 11-11-2015
Procedure Assessment of health and social care needs (procedure) 11-11-2015
Procedure Screening for domestic abuse (procedure) 11-11-2015
Procedure Depression screening (procedure) 11-11-2015
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 11-11-2015
Procedure Assessment of substance use (procedure) 11-11-2015
Procedure Screening for drug abuse (procedure) 11-11-2015
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 11-11-2015
Immunization Influenza, seasonal, injectable, preservative free 11-11-2015
Encounter General examination of patient (procedure) 02-03-2016
Observation Glucose [Mass/volume] in Serum or Plasma 02-03-2016 90.02 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 02-03-2016 17.27 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 02-03-2016 1.9901 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 02-03-2016 8.76 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 02-03-2016 136.41 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 02-03-2016 4.92 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 02-03-2016 106.15 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 02-03-2016 24.56 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 02-03-2016 63.084 mL/min/{1.73_m2}
Observation Appearance of Urine 02-03-2016
Observation Odor of Urine 02-03-2016
Observation Clarity of Urine 02-03-2016
Observation Color of Urine 02-03-2016
Observation Glucose [Mass/volume] in Urine by Test strip 02-03-2016 1.8091 mg/dL
Observation Glucose [Presence] in Urine by Test strip 02-03-2016
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 02-03-2016 1.1927 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 02-03-2016
Observation Ketones [Mass/volume] in Urine by Test strip 02-03-2016 19.779 mg/dL
Observation Ketones [Presence] in Urine by Test strip 02-03-2016
Observation Specific gravity of Urine by Test strip 02-03-2016 1.0083 {nominal}
Observation pH of Urine by Test strip 02-03-2016 6.6643 pH
Observation Protein [Mass/volume] in Urine by Test strip 02-03-2016 220.5 mg/dL
Observation Protein [Presence] in Urine by Test strip 02-03-2016
Observation Nitrite [Presence] in Urine by Test strip 02-03-2016
Observation Hemoglobin [Presence] in Urine by Test strip 02-03-2016
Observation Leukocyte esterase [Presence] in Urine by Test strip 02-03-2016
Observation Body Height 02-03-2016 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 02-03-2016 2 {score}
Observation Body Weight 02-03-2016 82.2 kg
Observation Body mass index (BMI) [Ratio] 02-03-2016 27.34 kg/m2
Observation Blood pressure panel with all children optional 02-03-2016
Observation Heart rate 02-03-2016 97 /min
Observation Respiratory rate 02-03-2016 14 /min
Observation Tobacco smoking status 02-03-2016
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 02-03-2016
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 02-03-2016 1 {score}
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 02-03-2016 2 {score}
Observation Total score [AUDIT-C] 02-03-2016 1 {score}
Procedure Medication Reconciliation (procedure) 02-03-2016
Procedure Assessment of health and social care needs (procedure) 02-03-2016
Procedure Assessment of anxiety (procedure) 02-03-2016
Procedure Depression screening (procedure) 02-03-2016
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 02-03-2016
Procedure Assessment of substance use (procedure) 02-03-2016
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 02-03-2016
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 02-03-2016
Encounter Encounter for check up (procedure) 03-09-2016
Observation Glucose [Mass/volume] in Serum or Plasma 03-09-2016 85.64 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 03-09-2016 17.53 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 03-09-2016 1.9517 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 03-09-2016 9.3 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 03-09-2016 137.48 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 03-09-2016 4.12 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 03-09-2016 103.77 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 03-09-2016 20.66 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 03-09-2016 62.115 mL/min/{1.73_m2}
Observation Appearance of Urine 03-09-2016
Observation Odor of Urine 03-09-2016
Observation Clarity of Urine 03-09-2016
Observation Color of Urine 03-09-2016
Observation Glucose [Mass/volume] in Urine by Test strip 03-09-2016 1.4541 mg/dL
Observation Glucose [Presence] in Urine by Test strip 03-09-2016
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 03-09-2016 0.89556 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 03-09-2016
Observation Ketones [Mass/volume] in Urine by Test strip 03-09-2016 6.5177 mg/dL
Observation Ketones [Presence] in Urine by Test strip 03-09-2016
Observation Specific gravity of Urine by Test strip 03-09-2016 1.0102 {nominal}
Observation pH of Urine by Test strip 03-09-2016 5.6665 pH
Observation Protein [Mass/volume] in Urine by Test strip 03-09-2016 270.07 mg/dL
Observation Protein [Presence] in Urine by Test strip 03-09-2016
Observation Nitrite [Presence] in Urine by Test strip 03-09-2016
Observation Hemoglobin [Presence] in Urine by Test strip 03-09-2016
Observation Leukocyte esterase [Presence] in Urine by Test strip 03-09-2016
Observation Body Height 03-09-2016 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 03-09-2016 4 {score}
Observation Body Weight 03-09-2016 82.2 kg
Observation Body mass index (BMI) [Ratio] 03-09-2016 27.34 kg/m2
Observation Blood pressure panel with all children optional 03-09-2016
Observation Heart rate 03-09-2016 89 /min
Observation Respiratory rate 03-09-2016 16 /min
Observation Tobacco smoking status 03-09-2016
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 03-09-2016
Observation Total score [DAST-10] 03-09-2016 2 {score}
Procedure Assessment of health and social care needs (procedure) 03-09-2016
Procedure Assessment of substance use (procedure) 03-09-2016
Procedure Screening for drug abuse (procedure) 03-09-2016
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 03-09-2016
Encounter Encounter for check up (procedure) 08-03-2016
Observation Glucose [Mass/volume] in Serum or Plasma 08-03-2016 64.03 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 08-03-2016 16.21 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 08-03-2016 2.0449 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 08-03-2016 9.9 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 08-03-2016 143.85 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 08-03-2016 5.12 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 08-03-2016 103.99 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 08-03-2016 20.03 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 08-03-2016 87.933 mL/min/{1.73_m2}
Observation Appearance of Urine 08-03-2016
Observation Odor of Urine 08-03-2016
Observation Clarity of Urine 08-03-2016
Observation Color of Urine 08-03-2016
Observation Glucose [Mass/volume] in Urine by Test strip 08-03-2016 1.3952 mg/dL
Observation Glucose [Presence] in Urine by Test strip 08-03-2016
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 08-03-2016 1.2348 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 08-03-2016
Observation Ketones [Mass/volume] in Urine by Test strip 08-03-2016 2.5511 mg/dL
Observation Ketones [Presence] in Urine by Test strip 08-03-2016
Observation Specific gravity of Urine by Test strip 08-03-2016 1.0077 {nominal}
Observation pH of Urine by Test strip 08-03-2016 6.8131 pH
Observation Protein [Mass/volume] in Urine by Test strip 08-03-2016 306.91 mg/dL
Observation Protein [Presence] in Urine by Test strip 08-03-2016
Observation Nitrite [Presence] in Urine by Test strip 08-03-2016
Observation Hemoglobin [Presence] in Urine by Test strip 08-03-2016
Observation Leukocyte esterase [Presence] in Urine by Test strip 08-03-2016
Observation Body Height 08-03-2016 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 08-03-2016 0 {score}
Observation Body Weight 08-03-2016 82.2 kg
Observation Body mass index (BMI) [Ratio] 08-03-2016 27.34 kg/m2
Observation Blood pressure panel with all children optional 08-03-2016
Observation Heart rate 08-03-2016 65 /min
Observation Respiratory rate 08-03-2016 14 /min
Observation Tobacco smoking status 08-03-2016
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 08-03-2016
Observation Fall risk total [Morse Fall Scale] 08-03-2016 39 {#}
Observation Fall risk level [Morse Fall Scale] 08-03-2016
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 08-03-2016 1 {score}
Observation Total score [AUDIT-C] 08-03-2016 1 {score}
Procedure Assessment of health and social care needs (procedure) 08-03-2016
Procedure Assessment using Morse Fall Scale (procedure) 08-03-2016
Procedure Depression screening (procedure) 08-03-2016
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 08-03-2016
Procedure Assessment of substance use (procedure) 08-03-2016
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 08-03-2016
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 08-03-2016
Immunization Pneumococcal conjugate PCV 13 08-03-2016
Encounter General examination of patient (procedure) 02-08-2017
Condition Has a criminal record (finding) 02-08-2017
Observation Glucose [Mass/volume] in Serum or Plasma 02-08-2017 84.78 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 02-08-2017 9.76 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 02-08-2017 2.0574 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 02-08-2017 9.5 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 02-08-2017 137.94 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 02-08-2017 3.87 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 02-08-2017 106.56 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 02-08-2017 26.75 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 02-08-2017 87.275 mL/min/{1.73_m2}
Observation Appearance of Urine 02-08-2017
Observation Odor of Urine 02-08-2017
Observation Clarity of Urine 02-08-2017
Observation Color of Urine 02-08-2017
Observation Glucose [Mass/volume] in Urine by Test strip 02-08-2017 2.414 mg/dL
Observation Glucose [Presence] in Urine by Test strip 02-08-2017
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 02-08-2017 0.4651 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 02-08-2017
Observation Ketones [Mass/volume] in Urine by Test strip 02-08-2017 12.536 mg/dL
Observation Ketones [Presence] in Urine by Test strip 02-08-2017
Observation Specific gravity of Urine by Test strip 02-08-2017 1.0378 {nominal}
Observation pH of Urine by Test strip 02-08-2017 6.9724 pH
Observation Protein [Mass/volume] in Urine by Test strip 02-08-2017 192.76 mg/dL
Observation Protein [Presence] in Urine by Test strip 02-08-2017
Observation Nitrite [Presence] in Urine by Test strip 02-08-2017
Observation Hemoglobin [Presence] in Urine by Test strip 02-08-2017
Observation Leukocyte esterase [Presence] in Urine by Test strip 02-08-2017
Observation Body Height 02-08-2017 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 02-08-2017 2 {score}
Observation Body Weight 02-08-2017 82.2 kg
Observation Body mass index (BMI) [Ratio] 02-08-2017 27.34 kg/m2
Observation Blood pressure panel with all children optional 02-08-2017
Observation Heart rate 02-08-2017 95 /min
Observation Respiratory rate 02-08-2017 13 /min
Observation Tobacco smoking status 02-08-2017
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 02-08-2017
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 02-08-2017 12 {score}
Observation Fall risk total [Morse Fall Scale] 02-08-2017 14 {#}
Observation Fall risk level [Morse Fall Scale] 02-08-2017
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 02-08-2017 0 {score}
Observation Total score [AUDIT-C] 02-08-2017 1 {score}
Procedure Assessment of health and social care needs (procedure) 02-08-2017
Procedure Assessment of anxiety (procedure) 02-08-2017
Procedure Assessment using Morse Fall Scale (procedure) 02-08-2017
Procedure Depression screening (procedure) 02-08-2017
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 02-08-2017
Procedure Assessment of substance use (procedure) 02-08-2017
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 02-08-2017
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 02-08-2017
Immunization Influenza, seasonal, injectable, preservative free 02-08-2017
Encounter General examination of patient (procedure) 02-14-2018
Observation Glucose [Mass/volume] in Serum or Plasma 02-14-2018 74.28 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 02-14-2018 18.46 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 02-14-2018 2.019 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 02-14-2018 9.9 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 02-14-2018 142.19 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 02-14-2018 4.23 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 02-14-2018 106.74 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 02-14-2018 24.1 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 02-14-2018 61.475 mL/min/{1.73_m2}
Observation Appearance of Urine 02-14-2018
Observation Odor of Urine 02-14-2018
Observation Clarity of Urine 02-14-2018
Observation Color of Urine 02-14-2018
Observation Glucose [Mass/volume] in Urine by Test strip 02-14-2018 2.3537 mg/dL
Observation Glucose [Presence] in Urine by Test strip 02-14-2018
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 02-14-2018 0.78819 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 02-14-2018
Observation Ketones [Mass/volume] in Urine by Test strip 02-14-2018 15.668 mg/dL
Observation Ketones [Presence] in Urine by Test strip 02-14-2018
Observation Specific gravity of Urine by Test strip 02-14-2018 1.0308 {nominal}
Observation pH of Urine by Test strip 02-14-2018 5.6766 pH
Observation Protein [Mass/volume] in Urine by Test strip 02-14-2018 175.53 mg/dL
Observation Protein [Presence] in Urine by Test strip 02-14-2018
Observation Nitrite [Presence] in Urine by Test strip 02-14-2018
Observation Hemoglobin [Presence] in Urine by Test strip 02-14-2018
Observation Leukocyte esterase [Presence] in Urine by Test strip 02-14-2018
Observation Body Height 02-14-2018 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 02-14-2018 2 {score}
Observation Body Weight 02-14-2018 82.2 kg
Observation Body mass index (BMI) [Ratio] 02-14-2018 27.34 kg/m2
Observation Blood pressure panel with all children optional 02-14-2018
Observation Heart rate 02-14-2018 84 /min
Observation Respiratory rate 02-14-2018 12 /min
Observation Cholesterol [Mass/volume] in Serum or Plasma 02-14-2018 168.52 mg/dL
Observation Triglycerides 02-14-2018 143.75 mg/dL
Observation Low Density Lipoprotein Cholesterol 02-14-2018 81.34 mg/dL
Observation Cholesterol in HDL [Mass/volume] in Serum or Plasma 02-14-2018 58.43 mg/dL
Observation Tobacco smoking status 02-14-2018
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 02-14-2018
Observation Fall risk total [Morse Fall Scale] 02-14-2018 61 {#}
Observation Fall risk level [Morse Fall Scale] 02-14-2018
Observation Total score [HARK] 02-14-2018 0 {score}
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 02-14-2018 2 {score}
Observation Total score [AUDIT-C] 02-14-2018 1 {score}
Procedure Medication Reconciliation (procedure) 02-14-2018
Procedure Assessment of health and social care needs (procedure) 02-14-2018
Procedure Assessment using Morse Fall Scale (procedure) 02-14-2018
Procedure Screening for domestic abuse (procedure) 02-14-2018
Procedure Depression screening (procedure) 02-14-2018
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 02-14-2018
Procedure Assessment of substance use (procedure) 02-14-2018
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 02-14-2018
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 02-14-2018
Immunization Influenza, seasonal, injectable, preservative free 02-14-2018
Immunization pneumococcal polysaccharide vaccine, 23 valent 02-14-2018
Encounter Encounter for check up (procedure) 08-29-2018
Condition Chronic kidney disease stage 3 (disorder) 08-29-2018
Condition Proteinuria due to type 2 diabetes mellitus (disorder) 08-29-2018
Observation Glucose [Mass/volume] in Serum or Plasma 08-29-2018 74.67 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 08-29-2018 18.2 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 08-29-2018 2.0759 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 08-29-2018 8.6 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 08-29-2018 143.91 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 08-29-2018 3.87 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 08-29-2018 106.12 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 08-29-2018 28.13 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 08-29-2018 51.963 mL/min/{1.73_m2}
Observation Appearance of Urine 08-29-2018
Observation Odor of Urine 08-29-2018
Observation Clarity of Urine 08-29-2018
Observation Color of Urine 08-29-2018
Observation Glucose [Mass/volume] in Urine by Test strip 08-29-2018 2.2462 mg/dL
Observation Glucose [Presence] in Urine by Test strip 08-29-2018
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 08-29-2018 0.78636 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 08-29-2018
Observation Ketones [Mass/volume] in Urine by Test strip 08-29-2018 0.25732 mg/dL
Observation Ketones [Presence] in Urine by Test strip 08-29-2018
Observation Specific gravity of Urine by Test strip 08-29-2018 1.0291 {nominal}
Observation pH of Urine by Test strip 08-29-2018 5.8535 pH
Observation Protein [Mass/volume] in Urine by Test strip 08-29-2018 253.07 mg/dL
Observation Protein [Presence] in Urine by Test strip 08-29-2018
Observation Nitrite [Presence] in Urine by Test strip 08-29-2018
Observation Hemoglobin [Presence] in Urine by Test strip 08-29-2018
Observation Leukocyte esterase [Presence] in Urine by Test strip 08-29-2018
Observation Body Height 08-29-2018 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 08-29-2018 3 {score}
Observation Body Weight 08-29-2018 82.2 kg
Observation Body mass index (BMI) [Ratio] 08-29-2018 27.34 kg/m2
Observation Blood pressure panel with all children optional 08-29-2018
Observation Heart rate 08-29-2018 66 /min
Observation Respiratory rate 08-29-2018 15 /min
Observation Tobacco smoking status 08-29-2018
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 08-29-2018
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 08-29-2018 2 {score}
Observation Fall risk total [Morse Fall Scale] 08-29-2018 37 {#}
Observation Fall risk level [Morse Fall Scale] 08-29-2018
Observation Total score [HARK] 08-29-2018 0 {score}
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 08-29-2018 2 {score}
Procedure Assessment of health and social care needs (procedure) 08-29-2018
Procedure Assessment of anxiety (procedure) 08-29-2018
Procedure Assessment using Morse Fall Scale (procedure) 08-29-2018
Procedure Screening for domestic abuse (procedure) 08-29-2018
Procedure Depression screening (procedure) 08-29-2018
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 08-29-2018
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 08-29-2018
Encounter Encounter for check up (procedure) 01-23-2019
Observation Glucose [Mass/volume] in Serum or Plasma 01-23-2019 88.65 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 01-23-2019 11.51 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 01-23-2019 2.0601 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 01-23-2019 8.96 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 01-23-2019 143.67 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 01-23-2019 4.76 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 01-23-2019 107.45 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 01-23-2019 21.29 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 01-23-2019 36.852 mL/min/{1.73_m2}
Observation Appearance of Urine 01-23-2019
Observation Odor of Urine 01-23-2019
Observation Clarity of Urine 01-23-2019
Observation Color of Urine 01-23-2019
Observation Glucose [Mass/volume] in Urine by Test strip 01-23-2019 0.55689 mg/dL
Observation Glucose [Presence] in Urine by Test strip 01-23-2019
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 01-23-2019 0.40535 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 01-23-2019
Observation Ketones [Mass/volume] in Urine by Test strip 01-23-2019 1.6015 mg/dL
Observation Ketones [Presence] in Urine by Test strip 01-23-2019
Observation Specific gravity of Urine by Test strip 01-23-2019 1.013 {nominal}
Observation pH of Urine by Test strip 01-23-2019 5.3228 pH
Observation Protein [Mass/volume] in Urine by Test strip 01-23-2019 265.21 mg/dL
Observation Protein [Presence] in Urine by Test strip 01-23-2019
Observation Nitrite [Presence] in Urine by Test strip 01-23-2019
Observation Hemoglobin [Presence] in Urine by Test strip 01-23-2019
Observation Leukocyte esterase [Presence] in Urine by Test strip 01-23-2019
Observation Body Height 01-23-2019 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 01-23-2019 2 {score}
Observation Body Weight 01-23-2019 82.2 kg
Observation Body mass index (BMI) [Ratio] 01-23-2019 27.34 kg/m2
Observation Blood pressure panel with all children optional 01-23-2019
Observation Heart rate 01-23-2019 97 /min
Observation Respiratory rate 01-23-2019 14 /min
Observation Leukocytes [#/volume] in Blood by Automated count 01-23-2019 3.6649 10*3/uL
Observation Erythrocytes [#/volume] in Blood by Automated count 01-23-2019 4.8375 10*6/uL
Observation Hemoglobin [Mass/volume] in Blood 01-23-2019 14.214 g/dL
Observation Hematocrit [Volume Fraction] of Blood by Automated count 01-23-2019 41.339 %
Observation MCV [Entitic volume] by Automated count 01-23-2019 82.234 fL
Observation MCH [Entitic mass] by Automated count 01-23-2019 30.324 pg
Observation MCHC [Mass/volume] by Automated count 01-23-2019 35.131 g/dL
Observation Erythrocyte distribution width [Entitic volume] by Automated count 01-23-2019 39.544 fL
Observation Platelets [#/volume] in Blood by Automated count 01-23-2019 310.25 10*3/uL
Observation Platelet distribution width [Entitic volume] in Blood by Automated count 01-23-2019 505.87 fL
Observation Platelet mean volume [Entitic volume] in Blood by Automated count 01-23-2019 11.35 fL
Observation Tobacco smoking status 01-23-2019
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 01-23-2019
Observation Fall risk total [Morse Fall Scale] 01-23-2019 31 {#}
Observation Fall risk level [Morse Fall Scale] 01-23-2019
Observation Total score [DAST-10] 01-23-2019 1 {score}
Procedure Assessment of health and social care needs (procedure) 01-23-2019
Procedure Assessment using Morse Fall Scale (procedure) 01-23-2019
Procedure Assessment of substance use (procedure) 01-23-2019
Procedure Screening for drug abuse (procedure) 01-23-2019
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 01-23-2019
Immunization Influenza, seasonal, injectable, preservative free 01-23-2019
Encounter General examination of patient (procedure) 02-20-2019
Observation Glucose [Mass/volume] in Serum or Plasma 02-20-2019 67.23 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 02-20-2019 16.53 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 02-20-2019 2.0862 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 02-20-2019 8.74 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 02-20-2019 137.45 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 02-20-2019 4.74 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 02-20-2019 102.98 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 02-20-2019 25.37 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 02-20-2019 39.075 mL/min/{1.73_m2}
Observation Appearance of Urine 02-20-2019
Observation Odor of Urine 02-20-2019
Observation Clarity of Urine 02-20-2019
Observation Color of Urine 02-20-2019
Observation Glucose [Mass/volume] in Urine by Test strip 02-20-2019 1.175 mg/dL
Observation Glucose [Presence] in Urine by Test strip 02-20-2019
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 02-20-2019 1.1895 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 02-20-2019
Observation Ketones [Mass/volume] in Urine by Test strip 02-20-2019 19.831 mg/dL
Observation Ketones [Presence] in Urine by Test strip 02-20-2019
Observation Specific gravity of Urine by Test strip 02-20-2019 1.0065 {nominal}
Observation pH of Urine by Test strip 02-20-2019 5.0049 pH
Observation Protein [Mass/volume] in Urine by Test strip 02-20-2019 396.15 mg/dL
Observation Protein [Presence] in Urine by Test strip 02-20-2019
Observation Nitrite [Presence] in Urine by Test strip 02-20-2019
Observation Hemoglobin [Presence] in Urine by Test strip 02-20-2019
Observation Leukocyte esterase [Presence] in Urine by Test strip 02-20-2019
Observation Body Height 02-20-2019 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 02-20-2019 0 {score}
Observation Body Weight 02-20-2019 82.2 kg
Observation Body mass index (BMI) [Ratio] 02-20-2019 27.34 kg/m2
Observation Blood pressure panel with all children optional 02-20-2019
Observation Heart rate 02-20-2019 61 /min
Observation Respiratory rate 02-20-2019 12 /min
Observation Tobacco smoking status 02-20-2019
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 02-20-2019
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 02-20-2019 1 {score}
Observation Fall risk total [Morse Fall Scale] 02-20-2019 38 {#}
Observation Fall risk level [Morse Fall Scale] 02-20-2019
Procedure Assessment of health and social care needs (procedure) 02-20-2019
Procedure Assessment of anxiety (procedure) 02-20-2019
Procedure Assessment using Morse Fall Scale (procedure) 02-20-2019
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 02-20-2019
Encounter Encounter for check up (procedure) 03-27-2019
Observation Glucose [Mass/volume] in Serum or Plasma 03-27-2019 67.14 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 03-27-2019 8.22 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 03-27-2019 1.907 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 03-27-2019 8.88 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 03-27-2019 136.9 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 03-27-2019 4.71 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 03-27-2019 105.78 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 03-27-2019 26.07 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 03-27-2019 38.513 mL/min/{1.73_m2}
Observation Appearance of Urine 03-27-2019
Observation Odor of Urine 03-27-2019
Observation Clarity of Urine 03-27-2019
Observation Color of Urine 03-27-2019
Observation Glucose [Mass/volume] in Urine by Test strip 03-27-2019 2.0949 mg/dL
Observation Glucose [Presence] in Urine by Test strip 03-27-2019
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 03-27-2019 1.4308 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 03-27-2019
Observation Ketones [Mass/volume] in Urine by Test strip 03-27-2019 8.4226 mg/dL
Observation Ketones [Presence] in Urine by Test strip 03-27-2019
Observation Specific gravity of Urine by Test strip 03-27-2019 1.036 {nominal}
Observation pH of Urine by Test strip 03-27-2019 6.4724 pH
Observation Protein [Mass/volume] in Urine by Test strip 03-27-2019 299.03 mg/dL
Observation Protein [Presence] in Urine by Test strip 03-27-2019
Observation Nitrite [Presence] in Urine by Test strip 03-27-2019
Observation Hemoglobin [Presence] in Urine by Test strip 03-27-2019
Observation Leukocyte esterase [Presence] in Urine by Test strip 03-27-2019
Observation Body Height 03-27-2019 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 03-27-2019 3 {score}
Observation Body Weight 03-27-2019 82.2 kg
Observation Body mass index (BMI) [Ratio] 03-27-2019 27.34 kg/m2
Observation Blood pressure panel with all children optional 03-27-2019
Observation Heart rate 03-27-2019 81 /min
Observation Respiratory rate 03-27-2019 13 /min
Observation Tobacco smoking status 03-27-2019
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 03-27-2019
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 03-27-2019 2 {score}
Observation Fall risk total [Morse Fall Scale] 03-27-2019 61 {#}
Observation Fall risk level [Morse Fall Scale] 03-27-2019
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 03-27-2019 0 {score}
Observation Total score [AUDIT-C] 03-27-2019 2 {score}
Procedure Medication Reconciliation (procedure) 03-27-2019
Procedure Assessment of health and social care needs (procedure) 03-27-2019
Procedure Assessment of anxiety (procedure) 03-27-2019
Procedure Assessment using Morse Fall Scale (procedure) 03-27-2019
Procedure Depression screening (procedure) 03-27-2019
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 03-27-2019
Procedure Assessment of substance use (procedure) 03-27-2019
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 03-27-2019
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 03-27-2019
Encounter Encounter for check up (procedure) 05-22-2019
Observation Glucose [Mass/volume] in Serum or Plasma 05-22-2019 81.96 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 05-22-2019 19.75 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 05-22-2019 1.9943 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 05-22-2019 8.73 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 05-22-2019 139.93 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 05-22-2019 3.9 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 05-22-2019 106.72 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 05-22-2019 22.15 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 05-22-2019 37.37 mL/min/{1.73_m2}
Observation Appearance of Urine 05-22-2019
Observation Odor of Urine 05-22-2019
Observation Clarity of Urine 05-22-2019
Observation Color of Urine 05-22-2019
Observation Glucose [Mass/volume] in Urine by Test strip 05-22-2019 0.55568 mg/dL
Observation Glucose [Presence] in Urine by Test strip 05-22-2019
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 05-22-2019 0.51372 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 05-22-2019
Observation Ketones [Mass/volume] in Urine by Test strip 05-22-2019 3.4722 mg/dL
Observation Ketones [Presence] in Urine by Test strip 05-22-2019
Observation Specific gravity of Urine by Test strip 05-22-2019 1.0248 {nominal}
Observation pH of Urine by Test strip 05-22-2019 5.3479 pH
Observation Protein [Mass/volume] in Urine by Test strip 05-22-2019 239.35 mg/dL
Observation Protein [Presence] in Urine by Test strip 05-22-2019
Observation Nitrite [Presence] in Urine by Test strip 05-22-2019
Observation Hemoglobin [Presence] in Urine by Test strip 05-22-2019
Observation Leukocyte esterase [Presence] in Urine by Test strip 05-22-2019
Observation Body Height 05-22-2019 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 05-22-2019 0 {score}
Observation Body Weight 05-22-2019 82.2 kg
Observation Body mass index (BMI) [Ratio] 05-22-2019 27.34 kg/m2
Observation Blood pressure panel with all children optional 05-22-2019
Observation Heart rate 05-22-2019 62 /min
Observation Respiratory rate 05-22-2019 13 /min
Observation Tobacco smoking status 05-22-2019
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 05-22-2019
Observation Fall risk total [Morse Fall Scale] 05-22-2019 25 {#}
Observation Fall risk level [Morse Fall Scale] 05-22-2019
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 05-22-2019 1 {score}
Observation Total score [AUDIT-C] 05-22-2019 1 {score}
Procedure Assessment of health and social care needs (procedure) 05-22-2019
Procedure Assessment using Morse Fall Scale (procedure) 05-22-2019
Procedure Depression screening (procedure) 05-22-2019
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 05-22-2019
Procedure Assessment of substance use (procedure) 05-22-2019
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 05-22-2019
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 05-22-2019
Encounter Encounter for check up (procedure) 09-18-2019
Observation Glucose [Mass/volume] in Serum or Plasma 09-18-2019 89.71 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 09-18-2019 7.52 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 09-18-2019 1.9442 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 09-18-2019 9.57 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 09-18-2019 143.68 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 09-18-2019 5.1 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 09-18-2019 102.97 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 09-18-2019 20.17 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 09-18-2019 45.728 mL/min/{1.73_m2}
Observation Appearance of Urine 09-18-2019
Observation Odor of Urine 09-18-2019
Observation Clarity of Urine 09-18-2019
Observation Color of Urine 09-18-2019
Observation Glucose [Mass/volume] in Urine by Test strip 09-18-2019 0.79494 mg/dL
Observation Glucose [Presence] in Urine by Test strip 09-18-2019
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 09-18-2019 0.91286 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 09-18-2019
Observation Ketones [Mass/volume] in Urine by Test strip 09-18-2019 12.338 mg/dL
Observation Ketones [Presence] in Urine by Test strip 09-18-2019
Observation Specific gravity of Urine by Test strip 09-18-2019 1.0048 {nominal}
Observation pH of Urine by Test strip 09-18-2019 6.557 pH
Observation Protein [Mass/volume] in Urine by Test strip 09-18-2019 321.99 mg/dL
Observation Protein [Presence] in Urine by Test strip 09-18-2019
Observation Nitrite [Presence] in Urine by Test strip 09-18-2019
Observation Hemoglobin [Presence] in Urine by Test strip 09-18-2019
Observation Leukocyte esterase [Presence] in Urine by Test strip 09-18-2019
Observation Body Height 09-18-2019 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 09-18-2019 3 {score}
Observation Body Weight 09-18-2019 82.2 kg
Observation Body mass index (BMI) [Ratio] 09-18-2019 27.34 kg/m2
Observation Blood pressure panel with all children optional 09-18-2019
Observation Heart rate 09-18-2019 80 /min
Observation Respiratory rate 09-18-2019 13 /min
Observation Tobacco smoking status 09-18-2019
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 09-18-2019
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 09-18-2019 1 {score}
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 09-18-2019 1 {score}
Observation Total score [DAST-10] 09-18-2019 2 {score}
Procedure Medication Reconciliation (procedure) 09-18-2019
Procedure Assessment of health and social care needs (procedure) 09-18-2019
Procedure Assessment of anxiety (procedure) 09-18-2019
Procedure Depression screening (procedure) 09-18-2019
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 09-18-2019
Procedure Assessment of substance use (procedure) 09-18-2019
Procedure Screening for drug abuse (procedure) 09-18-2019
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 09-18-2019
Encounter General examination of patient (procedure) 02-26-2020
Observation Glucose [Mass/volume] in Serum or Plasma 02-26-2020 87.67 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 02-26-2020 19.58 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 02-26-2020 2.0691 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 02-26-2020 10.11 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 02-26-2020 140.07 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 02-26-2020 4.15 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 02-26-2020 102.1 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 02-26-2020 25.67 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 02-26-2020 53.144 mL/min/{1.73_m2}
Observation Appearance of Urine 02-26-2020
Observation Odor of Urine 02-26-2020
Observation Clarity of Urine 02-26-2020
Observation Color of Urine 02-26-2020
Observation Glucose [Mass/volume] in Urine by Test strip 02-26-2020 1.3945 mg/dL
Observation Glucose [Presence] in Urine by Test strip 02-26-2020
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 02-26-2020 1.1313 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 02-26-2020
Observation Ketones [Mass/volume] in Urine by Test strip 02-26-2020 17.326 mg/dL
Observation Ketones [Presence] in Urine by Test strip 02-26-2020
Observation Specific gravity of Urine by Test strip 02-26-2020 1.0184 {nominal}
Observation pH of Urine by Test strip 02-26-2020 6.112 pH
Observation Protein [Mass/volume] in Urine by Test strip 02-26-2020 327.48 mg/dL
Observation Protein [Presence] in Urine by Test strip 02-26-2020
Observation Nitrite [Presence] in Urine by Test strip 02-26-2020
Observation Hemoglobin [Presence] in Urine by Test strip 02-26-2020
Observation Leukocyte esterase [Presence] in Urine by Test strip 02-26-2020
Observation Body Height 02-26-2020 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 02-26-2020 0 {score}
Observation Body Weight 02-26-2020 82.2 kg
Observation Body mass index (BMI) [Ratio] 02-26-2020 27.34 kg/m2
Observation Blood pressure panel with all children optional 02-26-2020
Observation Heart rate 02-26-2020 92 /min
Observation Respiratory rate 02-26-2020 16 /min
Observation Tobacco smoking status 02-26-2020
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 02-26-2020
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 02-26-2020 0 {score}
Observation Fall risk total [Morse Fall Scale] 02-26-2020 41 {#}
Observation Fall risk level [Morse Fall Scale] 02-26-2020
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 02-26-2020 2 {score}
Observation Total score [AUDIT-C] 02-26-2020 2 {score}
Procedure Assessment of health and social care needs (procedure) 02-26-2020
Procedure Assessment of anxiety (procedure) 02-26-2020
Procedure Assessment using Morse Fall Scale (procedure) 02-26-2020
Procedure Depression screening (procedure) 02-26-2020
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 02-26-2020
Procedure Assessment of substance use (procedure) 02-26-2020
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 02-26-2020
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 02-26-2020
Immunization Influenza, seasonal, injectable, preservative free 02-26-2020
Encounter Emergency room admission (procedure) 07-02-2020
MedicationRequest Naproxen sodium 220 MG Oral Tablet 07-02-2020
Encounter Encounter for check up (procedure) 07-15-2020
Observation Glucose [Mass/volume] in Serum or Plasma 07-15-2020 72.3 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 07-15-2020 11.3 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 07-15-2020 2.0712 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 07-15-2020 9 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 07-15-2020 136.93 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 07-15-2020 4.5 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 07-15-2020 103.66 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 07-15-2020 21.44 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 07-15-2020 44.377 mL/min/{1.73_m2}
Observation Appearance of Urine 07-15-2020
Observation Odor of Urine 07-15-2020
Observation Clarity of Urine 07-15-2020
Observation Color of Urine 07-15-2020
Observation Glucose [Mass/volume] in Urine by Test strip 07-15-2020 0.55159 mg/dL
Observation Glucose [Presence] in Urine by Test strip 07-15-2020
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 07-15-2020 1.1815 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 07-15-2020
Observation Ketones [Mass/volume] in Urine by Test strip 07-15-2020 15.562 mg/dL
Observation Ketones [Presence] in Urine by Test strip 07-15-2020
Observation Specific gravity of Urine by Test strip 07-15-2020 1.0149 {nominal}
Observation pH of Urine by Test strip 07-15-2020 5.2892 pH
Observation Protein [Mass/volume] in Urine by Test strip 07-15-2020 380.59 mg/dL
Observation Protein [Presence] in Urine by Test strip 07-15-2020
Observation Nitrite [Presence] in Urine by Test strip 07-15-2020
Observation Hemoglobin [Presence] in Urine by Test strip 07-15-2020
Observation Leukocyte esterase [Presence] in Urine by Test strip 07-15-2020
Observation Body Height 07-15-2020 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 07-15-2020 1 {score}
Observation Body Weight 07-15-2020 82.2 kg
Observation Body mass index (BMI) [Ratio] 07-15-2020 27.34 kg/m2
Observation Blood pressure panel with all children optional 07-15-2020
Observation Heart rate 07-15-2020 81 /min
Observation Respiratory rate 07-15-2020 13 /min
Observation Tobacco smoking status 07-15-2020
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 07-15-2020
Observation Fall risk total [Morse Fall Scale] 07-15-2020 23 {#}
Observation Fall risk level [Morse Fall Scale] 07-15-2020
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 07-15-2020 1 {score}
Observation Total score [AUDIT-C] 07-15-2020 2 {score}
Procedure Assessment of health and social care needs (procedure) 07-15-2020
Procedure Assessment using Morse Fall Scale (procedure) 07-15-2020
Procedure Depression screening (procedure) 07-15-2020
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 07-15-2020
Procedure Assessment of substance use (procedure) 07-15-2020
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 07-15-2020
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 07-15-2020
Encounter Encounter for check up (procedure) 11-11-2020
Observation Glucose [Mass/volume] in Serum or Plasma 11-11-2020 86.83 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 11-11-2020 7.26 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 11-11-2020 1.9622 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 11-11-2020 8.68 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 11-11-2020 142.47 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 11-11-2020 4.52 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 11-11-2020 104.9 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 11-11-2020 26.13 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 11-11-2020 51.785 mL/min/{1.73_m2}
Observation Appearance of Urine 11-11-2020
Observation Odor of Urine 11-11-2020
Observation Clarity of Urine 11-11-2020
Observation Color of Urine 11-11-2020
Observation Glucose [Mass/volume] in Urine by Test strip 11-11-2020 0.76749 mg/dL
Observation Glucose [Presence] in Urine by Test strip 11-11-2020
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 11-11-2020 0.2971 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 11-11-2020
Observation Ketones [Mass/volume] in Urine by Test strip 11-11-2020 18.475 mg/dL
Observation Ketones [Presence] in Urine by Test strip 11-11-2020
Observation Specific gravity of Urine by Test strip 11-11-2020 1.0124 {nominal}
Observation pH of Urine by Test strip 11-11-2020 6.4598 pH
Observation Protein [Mass/volume] in Urine by Test strip 11-11-2020 206.94 mg/dL
Observation Protein [Presence] in Urine by Test strip 11-11-2020
Observation Nitrite [Presence] in Urine by Test strip 11-11-2020
Observation Hemoglobin [Presence] in Urine by Test strip 11-11-2020
Observation Leukocyte esterase [Presence] in Urine by Test strip 11-11-2020
Observation Body Height 11-11-2020 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 11-11-2020 2 {score}
Observation Body Weight 11-11-2020 82.2 kg
Observation Body mass index (BMI) [Ratio] 11-11-2020 27.34 kg/m2
Observation Blood pressure panel with all children optional 11-11-2020
Observation Heart rate 11-11-2020 91 /min
Observation Respiratory rate 11-11-2020 13 /min
Observation Tobacco smoking status 11-11-2020
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 11-11-2020
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 11-11-2020 7 {score}
Observation Fall risk total [Morse Fall Scale] 11-11-2020 67 {#}
Observation Fall risk level [Morse Fall Scale] 11-11-2020
Observation Total score [HARK] 11-11-2020 0 {score}
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 11-11-2020 1 {score}
Observation Total score [DAST-10] 11-11-2020 2 {score}
Procedure Assessment of health and social care needs (procedure) 11-11-2020
Procedure Assessment of anxiety (procedure) 11-11-2020
Procedure Assessment using Morse Fall Scale (procedure) 11-11-2020
Procedure Screening for domestic abuse (procedure) 11-11-2020
Procedure Depression screening (procedure) 11-11-2020
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 11-11-2020
Procedure Assessment of substance use (procedure) 11-11-2020
Procedure Screening for drug abuse (procedure) 11-11-2020
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 11-11-2020
Immunization Influenza, seasonal, injectable, preservative free 11-11-2020
Encounter Encounter for check up (procedure) 12-16-2020
Observation Glucose [Mass/volume] in Serum or Plasma 12-16-2020 86.24 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 12-16-2020 12.75 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 12-16-2020 1.9346 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 12-16-2020 9.7 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 12-16-2020 141.87 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 12-16-2020 4.44 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 12-16-2020 109.94 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 12-16-2020 21.9 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 12-16-2020 55.597 mL/min/{1.73_m2}
Observation Appearance of Urine 12-16-2020
Observation Odor of Urine 12-16-2020
Observation Clarity of Urine 12-16-2020
Observation Color of Urine 12-16-2020
Observation Glucose [Mass/volume] in Urine by Test strip 12-16-2020 2.3555 mg/dL
Observation Glucose [Presence] in Urine by Test strip 12-16-2020
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 12-16-2020 1.1123 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 12-16-2020
Observation Ketones [Mass/volume] in Urine by Test strip 12-16-2020 19.41 mg/dL
Observation Ketones [Presence] in Urine by Test strip 12-16-2020
Observation Specific gravity of Urine by Test strip 12-16-2020 1.036 {nominal}
Observation pH of Urine by Test strip 12-16-2020 5.5437 pH
Observation Protein [Mass/volume] in Urine by Test strip 12-16-2020 344.56 mg/dL
Observation Protein [Presence] in Urine by Test strip 12-16-2020
Observation Nitrite [Presence] in Urine by Test strip 12-16-2020
Observation Hemoglobin [Presence] in Urine by Test strip 12-16-2020
Observation Leukocyte esterase [Presence] in Urine by Test strip 12-16-2020
Observation Body Height 12-16-2020 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 12-16-2020 1 {score}
Observation Body Weight 12-16-2020 82.2 kg
Observation Body mass index (BMI) [Ratio] 12-16-2020 27.34 kg/m2
Observation Blood pressure panel with all children optional 12-16-2020
Observation Heart rate 12-16-2020 78 /min
Observation Respiratory rate 12-16-2020 14 /min
Observation Tobacco smoking status 12-16-2020
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 12-16-2020
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 12-16-2020 2 {score}
Observation Total score [DAST-10] 12-16-2020 1 {score}
Procedure Medication Reconciliation (procedure) 12-16-2020
Procedure Assessment of health and social care needs (procedure) 12-16-2020
Procedure Depression screening (procedure) 12-16-2020
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 12-16-2020
Procedure Assessment of substance use (procedure) 12-16-2020
Procedure Screening for drug abuse (procedure) 12-16-2020
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 12-16-2020
Encounter General examination of patient (procedure) 03-03-2021
Observation Glucose [Mass/volume] in Serum or Plasma 03-03-2021 82.01 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 03-03-2021 12.14 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 03-03-2021 2.0304 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 03-03-2021 9.1 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 03-03-2021 139.64 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 03-03-2021 4.4 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 03-03-2021 110.05 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 03-03-2021 25.9 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 03-03-2021 34.71 mL/min/{1.73_m2}
Observation Appearance of Urine 03-03-2021
Observation Odor of Urine 03-03-2021
Observation Clarity of Urine 03-03-2021
Observation Color of Urine 03-03-2021
Observation Glucose [Mass/volume] in Urine by Test strip 03-03-2021 1.3498 mg/dL
Observation Glucose [Presence] in Urine by Test strip 03-03-2021
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 03-03-2021 0.36434 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 03-03-2021
Observation Ketones [Mass/volume] in Urine by Test strip 03-03-2021 11.105 mg/dL
Observation Ketones [Presence] in Urine by Test strip 03-03-2021
Observation Specific gravity of Urine by Test strip 03-03-2021 1.0342 {nominal}
Observation pH of Urine by Test strip 03-03-2021 5.8085 pH
Observation Protein [Mass/volume] in Urine by Test strip 03-03-2021 387 mg/dL
Observation Protein [Presence] in Urine by Test strip 03-03-2021
Observation Nitrite [Presence] in Urine by Test strip 03-03-2021
Observation Hemoglobin [Presence] in Urine by Test strip 03-03-2021
Observation Leukocyte esterase [Presence] in Urine by Test strip 03-03-2021
Observation Body Height 03-03-2021 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 03-03-2021 2 {score}
Observation Body Weight 03-03-2021 82.2 kg
Observation Body mass index (BMI) [Ratio] 03-03-2021 27.34 kg/m2
Observation Blood pressure panel with all children optional 03-03-2021
Observation Heart rate 03-03-2021 69 /min
Observation Respiratory rate 03-03-2021 14 /min
Observation Cholesterol [Mass/volume] in Serum or Plasma 03-03-2021 129.01 mg/dL
Observation Triglycerides 03-03-2021 126.73 mg/dL
Observation Low Density Lipoprotein Cholesterol 03-03-2021 38.11 mg/dL
Observation Cholesterol in HDL [Mass/volume] in Serum or Plasma 03-03-2021 65.55 mg/dL
Observation Tobacco smoking status 03-03-2021
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 03-03-2021
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 03-03-2021 1 {score}
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 03-03-2021 1 {score}
Observation Total score [AUDIT-C] 03-03-2021 0 {score}
Procedure Assessment of health and social care needs (procedure) 03-03-2021
Procedure Assessment of anxiety (procedure) 03-03-2021
Procedure Depression screening (procedure) 03-03-2021
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 03-03-2021
Procedure Assessment of substance use (procedure) 03-03-2021
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 03-03-2021
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 03-03-2021
Immunization SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose 03-03-2021
Encounter Encounter for check up (procedure) 03-10-2021
Observation Glucose [Mass/volume] in Serum or Plasma 03-10-2021 99.89 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 03-10-2021 12.79 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 03-10-2021 1.9792 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 03-10-2021 10.06 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 03-10-2021 141.4 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 03-10-2021 3.79 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 03-10-2021 102.48 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 03-10-2021 25.28 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 03-10-2021 45.216 mL/min/{1.73_m2}
Observation Appearance of Urine 03-10-2021
Observation Odor of Urine 03-10-2021
Observation Clarity of Urine 03-10-2021
Observation Color of Urine 03-10-2021
Observation Glucose [Mass/volume] in Urine by Test strip 03-10-2021 1.358 mg/dL
Observation Glucose [Presence] in Urine by Test strip 03-10-2021
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 03-10-2021 1.2693 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 03-10-2021
Observation Ketones [Mass/volume] in Urine by Test strip 03-10-2021 6.6724 mg/dL
Observation Ketones [Presence] in Urine by Test strip 03-10-2021
Observation Specific gravity of Urine by Test strip 03-10-2021 1.0155 {nominal}
Observation pH of Urine by Test strip 03-10-2021 6.5472 pH
Observation Protein [Mass/volume] in Urine by Test strip 03-10-2021 389.15 mg/dL
Observation Protein [Presence] in Urine by Test strip 03-10-2021
Observation Nitrite [Presence] in Urine by Test strip 03-10-2021
Observation Hemoglobin [Presence] in Urine by Test strip 03-10-2021
Observation Leukocyte esterase [Presence] in Urine by Test strip 03-10-2021
Procedure Medication Reconciliation (procedure) 03-10-2021
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 03-10-2021
Encounter Administration of vaccine to produce active immunity (procedure) 03-24-2021
Immunization SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose 03-24-2021
Encounter Encounter for check up (procedure) 04-14-2021
Observation Glucose [Mass/volume] in Serum or Plasma 04-14-2021 85.25 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 04-14-2021 19.55 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 04-14-2021 1.9534 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 04-14-2021 8.54 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 04-14-2021 143.85 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 04-14-2021 5.2 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 04-14-2021 108.93 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 04-14-2021 20.3 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 04-14-2021 46.216 mL/min/{1.73_m2}
Observation Appearance of Urine 04-14-2021
Observation Odor of Urine 04-14-2021
Observation Clarity of Urine 04-14-2021
Observation Color of Urine 04-14-2021
Observation Glucose [Mass/volume] in Urine by Test strip 04-14-2021 1.2636 mg/dL
Observation Glucose [Presence] in Urine by Test strip 04-14-2021
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 04-14-2021 1.3266 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 04-14-2021
Observation Ketones [Mass/volume] in Urine by Test strip 04-14-2021 2.4215 mg/dL
Observation Ketones [Presence] in Urine by Test strip 04-14-2021
Observation Specific gravity of Urine by Test strip 04-14-2021 1.0259 {nominal}
Observation pH of Urine by Test strip 04-14-2021 5.731 pH
Observation Protein [Mass/volume] in Urine by Test strip 04-14-2021 231.24 mg/dL
Observation Protein [Presence] in Urine by Test strip 04-14-2021
Observation Nitrite [Presence] in Urine by Test strip 04-14-2021
Observation Hemoglobin [Presence] in Urine by Test strip 04-14-2021
Observation Leukocyte esterase [Presence] in Urine by Test strip 04-14-2021
Observation Body Height 04-14-2021 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 04-14-2021 2 {score}
Observation Body Weight 04-14-2021 82.2 kg
Observation Body mass index (BMI) [Ratio] 04-14-2021 27.34 kg/m2
Observation Blood pressure panel with all children optional 04-14-2021
Observation Heart rate 04-14-2021 88 /min
Observation Respiratory rate 04-14-2021 13 /min
Observation Tobacco smoking status 04-14-2021
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 04-14-2021
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 04-14-2021 8 {score}
Observation Total score [HARK] 04-14-2021 0 {score}
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 04-14-2021 1 {score}
Observation Total score [AUDIT-C] 04-14-2021 2 {score}
Procedure Medication Reconciliation (procedure) 04-14-2021
Procedure Assessment of health and social care needs (procedure) 04-14-2021
Procedure Assessment of anxiety (procedure) 04-14-2021
Procedure Screening for domestic abuse (procedure) 04-14-2021
Procedure Depression screening (procedure) 04-14-2021
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 04-14-2021
Procedure Assessment of substance use (procedure) 04-14-2021
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 04-14-2021
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 04-14-2021
Encounter Encounter for check up (procedure) 08-11-2021
Observation Glucose [Mass/volume] in Serum or Plasma 08-11-2021 93.08 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 08-11-2021 9.63 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 08-11-2021 2.0631 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 08-11-2021 8.61 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 08-11-2021 138.14 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 08-11-2021 4.99 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 08-11-2021 110.36 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 08-11-2021 25.54 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 08-11-2021 48.15 mL/min/{1.73_m2}
Observation Appearance of Urine 08-11-2021
Observation Odor of Urine 08-11-2021
Observation Clarity of Urine 08-11-2021
Observation Color of Urine 08-11-2021
Observation Glucose [Mass/volume] in Urine by Test strip 08-11-2021 0.97536 mg/dL
Observation Glucose [Presence] in Urine by Test strip 08-11-2021
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 08-11-2021 1.3961 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 08-11-2021
Observation Ketones [Mass/volume] in Urine by Test strip 08-11-2021 0.21242 mg/dL
Observation Ketones [Presence] in Urine by Test strip 08-11-2021
Observation Specific gravity of Urine by Test strip 08-11-2021 1.0319 {nominal}
Observation pH of Urine by Test strip 08-11-2021 5.2875 pH
Observation Protein [Mass/volume] in Urine by Test strip 08-11-2021 252.23 mg/dL
Observation Protein [Presence] in Urine by Test strip 08-11-2021
Observation Nitrite [Presence] in Urine by Test strip 08-11-2021
Observation Hemoglobin [Presence] in Urine by Test strip 08-11-2021
Observation Leukocyte esterase [Presence] in Urine by Test strip 08-11-2021
Observation Body Height 08-11-2021 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 08-11-2021 3 {score}
Observation Body Weight 08-11-2021 82.2 kg
Observation Body mass index (BMI) [Ratio] 08-11-2021 27.34 kg/m2
Observation Blood pressure panel with all children optional 08-11-2021
Observation Heart rate 08-11-2021 72 /min
Observation Respiratory rate 08-11-2021 12 /min
Observation Tobacco smoking status 08-11-2021
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 08-11-2021
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 08-11-2021 1 {score}
Observation Fall risk total [Morse Fall Scale] 08-11-2021 41 {#}
Observation Fall risk level [Morse Fall Scale] 08-11-2021
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 08-11-2021 1 {score}
Observation Total score [AUDIT-C] 08-11-2021 0 {score}
Procedure Medication Reconciliation (procedure) 08-11-2021
Procedure Assessment of health and social care needs (procedure) 08-11-2021
Procedure Assessment of anxiety (procedure) 08-11-2021
Procedure Assessment using Morse Fall Scale (procedure) 08-11-2021
Procedure Depression screening (procedure) 08-11-2021
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 08-11-2021
Procedure Assessment of substance use (procedure) 08-11-2021
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 08-11-2021
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 08-11-2021
Encounter Encounter for check up (procedure) 10-06-2021
Observation Glucose [Mass/volume] in Serum or Plasma 10-06-2021 91.81 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 10-06-2021 16.12 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 10-06-2021 2.0574 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 10-06-2021 10.02 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 10-06-2021 138.49 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 10-06-2021 3.96 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 10-06-2021 105.81 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 10-06-2021 22.13 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 10-06-2021 57.954 mL/min/{1.73_m2}
Observation Appearance of Urine 10-06-2021
Observation Odor of Urine 10-06-2021
Observation Clarity of Urine 10-06-2021
Observation Color of Urine 10-06-2021
Observation Glucose [Mass/volume] in Urine by Test strip 10-06-2021 1.9772 mg/dL
Observation Glucose [Presence] in Urine by Test strip 10-06-2021
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 10-06-2021 0.88301 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 10-06-2021
Observation Ketones [Mass/volume] in Urine by Test strip 10-06-2021 9.7361 mg/dL
Observation Ketones [Presence] in Urine by Test strip 10-06-2021
Observation Specific gravity of Urine by Test strip 10-06-2021 1.0275 {nominal}
Observation pH of Urine by Test strip 10-06-2021 5.9285 pH
Observation Protein [Mass/volume] in Urine by Test strip 10-06-2021 344.6 mg/dL
Observation Protein [Presence] in Urine by Test strip 10-06-2021
Observation Nitrite [Presence] in Urine by Test strip 10-06-2021
Observation Hemoglobin [Presence] in Urine by Test strip 10-06-2021
Observation Leukocyte esterase [Presence] in Urine by Test strip 10-06-2021
Observation Body Height 10-06-2021 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 10-06-2021 1 {score}
Observation Body Weight 10-06-2021 82.2 kg
Observation Body mass index (BMI) [Ratio] 10-06-2021 27.34 kg/m2
Observation Blood pressure panel with all children optional 10-06-2021
Observation Heart rate 10-06-2021 78 /min
Observation Respiratory rate 10-06-2021 15 /min
Observation Tobacco smoking status 10-06-2021
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 10-06-2021
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 10-06-2021 3 {score}
Observation Fall risk total [Morse Fall Scale] 10-06-2021 97 {#}
Observation Fall risk level [Morse Fall Scale] 10-06-2021
Observation Total score [HARK] 10-06-2021 2 {score}
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 10-06-2021 1 {score}
Observation Total score [AUDIT-C] 10-06-2021 1 {score}
Procedure Medication Reconciliation (procedure) 10-06-2021
Procedure Assessment of health and social care needs (procedure) 10-06-2021
Procedure Assessment of anxiety (procedure) 10-06-2021
Procedure Assessment using Morse Fall Scale (procedure) 10-06-2021
Procedure Screening for domestic abuse (procedure) 10-06-2021
Procedure Depression screening (procedure) 10-06-2021
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 10-06-2021
Procedure Assessment of substance use (procedure) 10-06-2021
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 10-06-2021
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 10-06-2021
Immunization Influenza, seasonal, injectable, preservative free 10-06-2021
Encounter Emergency room admission (procedure) 12-22-2021
Observation Glucose [Mass/volume] in Serum or Plasma 12-22-2021 85.1 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 12-22-2021 12.25 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 12-22-2021 1.9058 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 12-22-2021 9.82 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 12-22-2021 136.16 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 12-22-2021 4.89 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 12-22-2021 106.62 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 12-22-2021 24.92 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 12-22-2021 40.102 mL/min/{1.73_m2}
Observation Appearance of Urine 12-22-2021
Observation Odor of Urine 12-22-2021
Observation Clarity of Urine 12-22-2021
Observation Color of Urine 12-22-2021
Observation Glucose [Mass/volume] in Urine by Test strip 12-22-2021 1.6219 mg/dL
Observation Glucose [Presence] in Urine by Test strip 12-22-2021
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 12-22-2021 1.4963 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 12-22-2021
Observation Ketones [Mass/volume] in Urine by Test strip 12-22-2021 5.7173 mg/dL
Observation Ketones [Presence] in Urine by Test strip 12-22-2021
Observation Specific gravity of Urine by Test strip 12-22-2021 1.0364 {nominal}
Observation pH of Urine by Test strip 12-22-2021 6.6324 pH
Observation Protein [Mass/volume] in Urine by Test strip 12-22-2021 397.75 mg/dL
Observation Protein [Presence] in Urine by Test strip 12-22-2021
Observation Nitrite [Presence] in Urine by Test strip 12-22-2021
Observation Hemoglobin [Presence] in Urine by Test strip 12-22-2021
Observation Leukocyte esterase [Presence] in Urine by Test strip 12-22-2021
Observation Body Height 12-22-2021 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 12-22-2021 3 {score}
Observation Body Weight 12-22-2021 82.2 kg
Observation Body mass index (BMI) [Ratio] 12-22-2021 27.34 kg/m2
Observation Blood pressure panel with all children optional 12-22-2021
Observation Heart rate 12-22-2021 63 /min
Observation Respiratory rate 12-22-2021 16 /min
Observation Tobacco smoking status 12-22-2021
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 12-22-2021
Observation Fall risk total [Morse Fall Scale] 12-22-2021 15 {#}
Observation Fall risk level [Morse Fall Scale] 12-22-2021
Observation Total score [AUDIT-C] 12-22-2021 1 {score}
Procedure Assessment of health and social care needs (procedure) 12-22-2021
Procedure Assessment using Morse Fall Scale (procedure) 12-22-2021
Procedure Assessment of substance use (procedure) 12-22-2021
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 12-22-2021
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 12-22-2021
Encounter Urgent care clinic (environment) 12-29-2021
Observation Glucose [Mass/volume] in Serum or Plasma 12-29-2021 81.73 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 12-29-2021 16.31 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 12-29-2021 1.9425 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 12-29-2021 9.16 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 12-29-2021 143.43 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 12-29-2021 4.32 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 12-29-2021 110.68 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 12-29-2021 28.4 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 12-29-2021 57.678 mL/min/{1.73_m2}
Observation Appearance of Urine 12-29-2021
Observation Odor of Urine 12-29-2021
Observation Clarity of Urine 12-29-2021
Observation Color of Urine 12-29-2021
Observation Glucose [Mass/volume] in Urine by Test strip 12-29-2021 1.9886 mg/dL
Observation Glucose [Presence] in Urine by Test strip 12-29-2021
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 12-29-2021 1.3986 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 12-29-2021
Observation Ketones [Mass/volume] in Urine by Test strip 12-29-2021 18.601 mg/dL
Observation Ketones [Presence] in Urine by Test strip 12-29-2021
Observation Specific gravity of Urine by Test strip 12-29-2021 1.0046 {nominal}
Observation pH of Urine by Test strip 12-29-2021 6.3411 pH
Observation Protein [Mass/volume] in Urine by Test strip 12-29-2021 305.84 mg/dL
Observation Protein [Presence] in Urine by Test strip 12-29-2021
Observation Nitrite [Presence] in Urine by Test strip 12-29-2021
Observation Hemoglobin [Presence] in Urine by Test strip 12-29-2021
Observation Leukocyte esterase [Presence] in Urine by Test strip 12-29-2021
Procedure Medication Reconciliation (procedure) 12-29-2021
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 12-29-2021
Encounter Urgent care clinic (environment) 01-05-2022
Observation Glucose [Mass/volume] in Serum or Plasma 01-05-2022 79.95 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 01-05-2022 14.19 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 01-05-2022 1.9747 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 01-05-2022 10.04 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 01-05-2022 138.9 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 01-05-2022 4.67 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 01-05-2022 110.66 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 01-05-2022 28.62 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 01-05-2022 35.136 mL/min/{1.73_m2}
Observation Appearance of Urine 01-05-2022
Observation Odor of Urine 01-05-2022
Observation Clarity of Urine 01-05-2022
Observation Color of Urine 01-05-2022
Observation Glucose [Mass/volume] in Urine by Test strip 01-05-2022 1.2454 mg/dL
Observation Glucose [Presence] in Urine by Test strip 01-05-2022
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 01-05-2022 0.65743 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 01-05-2022
Observation Ketones [Mass/volume] in Urine by Test strip 01-05-2022 1.3684 mg/dL
Observation Ketones [Presence] in Urine by Test strip 01-05-2022
Observation Specific gravity of Urine by Test strip 01-05-2022 1.0187 {nominal}
Observation pH of Urine by Test strip 01-05-2022 5.9153 pH
Observation Protein [Mass/volume] in Urine by Test strip 01-05-2022 229.7 mg/dL
Observation Protein [Presence] in Urine by Test strip 01-05-2022
Observation Nitrite [Presence] in Urine by Test strip 01-05-2022
Observation Hemoglobin [Presence] in Urine by Test strip 01-05-2022
Observation Leukocyte esterase [Presence] in Urine by Test strip 01-05-2022
Observation Body Height 01-05-2022 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 01-05-2022 3 {score}
Observation Body Weight 01-05-2022 82.2 kg
Observation Body mass index (BMI) [Ratio] 01-05-2022 27.34 kg/m2
Observation Blood pressure panel with all children optional 01-05-2022
Observation Heart rate 01-05-2022 81 /min
Observation Respiratory rate 01-05-2022 14 /min
Observation Tobacco smoking status 01-05-2022
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 01-05-2022
Observation Fall risk total [Morse Fall Scale] 01-05-2022 14 {#}
Observation Fall risk level [Morse Fall Scale] 01-05-2022
Observation Total score [HARK] 01-05-2022 0 {score}
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 01-05-2022 0 {score}
Procedure Assessment of health and social care needs (procedure) 01-05-2022
Procedure Assessment using Morse Fall Scale (procedure) 01-05-2022
Procedure Screening for domestic abuse (procedure) 01-05-2022
Procedure Depression screening (procedure) 01-05-2022
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 01-05-2022
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 01-05-2022
Encounter Encounter for check up (procedure) 01-12-2022
Observation Glucose [Mass/volume] in Serum or Plasma 01-12-2022 74.07 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 01-12-2022 12.81 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 01-12-2022 2.0335 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 01-12-2022 8.51 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 01-12-2022 136.3 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 01-12-2022 5.05 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 01-12-2022 103.7 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 01-12-2022 24.4 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 01-12-2022 52.342 mL/min/{1.73_m2}
Observation Appearance of Urine 01-12-2022
Observation Odor of Urine 01-12-2022
Observation Clarity of Urine 01-12-2022
Observation Color of Urine 01-12-2022
Observation Glucose [Mass/volume] in Urine by Test strip 01-12-2022 1.1765 mg/dL
Observation Glucose [Presence] in Urine by Test strip 01-12-2022
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 01-12-2022 1.0759 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 01-12-2022
Observation Ketones [Mass/volume] in Urine by Test strip 01-12-2022 2.5428 mg/dL
Observation Ketones [Presence] in Urine by Test strip 01-12-2022
Observation Specific gravity of Urine by Test strip 01-12-2022 1.0211 {nominal}
Observation pH of Urine by Test strip 01-12-2022 6.6212 pH
Observation Protein [Mass/volume] in Urine by Test strip 01-12-2022 345.4 mg/dL
Observation Protein [Presence] in Urine by Test strip 01-12-2022
Observation Nitrite [Presence] in Urine by Test strip 01-12-2022
Observation Hemoglobin [Presence] in Urine by Test strip 01-12-2022
Observation Leukocyte esterase [Presence] in Urine by Test strip 01-12-2022
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 01-12-2022
Encounter Encounter for symptom 01-19-2022
MedicationRequest Amoxicillin 250 MG / Clavulanate 125 MG Oral Tablet 01-19-2022
Encounter Urgent care clinic (environment) 02-09-2022
Observation Glucose [Mass/volume] in Serum or Plasma 02-09-2022 99.73 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 02-09-2022 15.35 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 02-09-2022 2.0798 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 02-09-2022 8.98 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 02-09-2022 141.42 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 02-09-2022 3.85 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 02-09-2022 106.66 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 02-09-2022 21.04 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 02-09-2022 35.33 mL/min/{1.73_m2}
Observation Appearance of Urine 02-09-2022
Observation Odor of Urine 02-09-2022
Observation Clarity of Urine 02-09-2022
Observation Color of Urine 02-09-2022
Observation Glucose [Mass/volume] in Urine by Test strip 02-09-2022 2.4667 mg/dL
Observation Glucose [Presence] in Urine by Test strip 02-09-2022
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 02-09-2022 0.73555 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 02-09-2022
Observation Ketones [Mass/volume] in Urine by Test strip 02-09-2022 15.769 mg/dL
Observation Ketones [Presence] in Urine by Test strip 02-09-2022
Observation Specific gravity of Urine by Test strip 02-09-2022 1.0354 {nominal}
Observation pH of Urine by Test strip 02-09-2022 6.7402 pH
Observation Protein [Mass/volume] in Urine by Test strip 02-09-2022 226.07 mg/dL
Observation Protein [Presence] in Urine by Test strip 02-09-2022
Observation Nitrite [Presence] in Urine by Test strip 02-09-2022
Observation Hemoglobin [Presence] in Urine by Test strip 02-09-2022
Observation Leukocyte esterase [Presence] in Urine by Test strip 02-09-2022
Observation Body Height 02-09-2022 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 02-09-2022 3 {score}
Observation Body Weight 02-09-2022 82.2 kg
Observation Body mass index (BMI) [Ratio] 02-09-2022 27.34 kg/m2
Observation Blood pressure panel with all children optional 02-09-2022
Observation Heart rate 02-09-2022 88 /min
Observation Respiratory rate 02-09-2022 15 /min
Observation Tobacco smoking status 02-09-2022
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 02-09-2022
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 02-09-2022 3 {score}
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 02-09-2022 1 {score}
Observation Total score [AUDIT-C] 02-09-2022 1 {score}
Procedure Medication Reconciliation (procedure) 02-09-2022
Procedure Assessment of health and social care needs (procedure) 02-09-2022
Procedure Assessment of anxiety (procedure) 02-09-2022
Procedure Depression screening (procedure) 02-09-2022
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 02-09-2022
Procedure Assessment of substance use (procedure) 02-09-2022
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 02-09-2022
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 02-09-2022
Encounter Encounter for check up (procedure) 02-16-2022
Observation Glucose [Mass/volume] in Serum or Plasma 02-16-2022 86.69 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 02-16-2022 9.73 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 02-16-2022 2.0933 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 02-16-2022 9.22 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 02-16-2022 140.69 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 02-16-2022 3.82 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 02-16-2022 106.53 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 02-16-2022 28.78 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 02-16-2022 53.514 mL/min/{1.73_m2}
Observation Appearance of Urine 02-16-2022
Observation Odor of Urine 02-16-2022
Observation Clarity of Urine 02-16-2022
Observation Color of Urine 02-16-2022
Observation Glucose [Mass/volume] in Urine by Test strip 02-16-2022 1.7442 mg/dL
Observation Glucose [Presence] in Urine by Test strip 02-16-2022
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 02-16-2022 1.3688 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 02-16-2022
Observation Ketones [Mass/volume] in Urine by Test strip 02-16-2022 5.4009 mg/dL
Observation Ketones [Presence] in Urine by Test strip 02-16-2022
Observation Specific gravity of Urine by Test strip 02-16-2022 1.0028 {nominal}
Observation pH of Urine by Test strip 02-16-2022 5.0344 pH
Observation Protein [Mass/volume] in Urine by Test strip 02-16-2022 389.59 mg/dL
Observation Protein [Presence] in Urine by Test strip 02-16-2022
Observation Nitrite [Presence] in Urine by Test strip 02-16-2022
Observation Hemoglobin [Presence] in Urine by Test strip 02-16-2022
Observation Leukocyte esterase [Presence] in Urine by Test strip 02-16-2022
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 02-16-2022
Encounter General examination of patient (procedure) 03-09-2022
Condition Social isolation (finding) 03-09-2022
Observation Glucose [Mass/volume] in Serum or Plasma 03-09-2022 66.72 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 03-09-2022 9.07 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 03-09-2022 1.9765 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 03-09-2022 8.92 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 03-09-2022 143.91 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 03-09-2022 5.11 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 03-09-2022 104.32 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 03-09-2022 21.6 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 03-09-2022 55.515 mL/min/{1.73_m2}
Observation Appearance of Urine 03-09-2022
Observation Odor of Urine 03-09-2022
Observation Clarity of Urine 03-09-2022
Observation Color of Urine 03-09-2022
Observation Glucose [Mass/volume] in Urine by Test strip 03-09-2022 1.7349 mg/dL
Observation Glucose [Presence] in Urine by Test strip 03-09-2022
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 03-09-2022 1.1396 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 03-09-2022
Observation Ketones [Mass/volume] in Urine by Test strip 03-09-2022 15.08 mg/dL
Observation Ketones [Presence] in Urine by Test strip 03-09-2022
Observation Specific gravity of Urine by Test strip 03-09-2022 1.0131 {nominal}
Observation pH of Urine by Test strip 03-09-2022 5.7764 pH
Observation Protein [Mass/volume] in Urine by Test strip 03-09-2022 397.68 mg/dL
Observation Protein [Presence] in Urine by Test strip 03-09-2022
Observation Nitrite [Presence] in Urine by Test strip 03-09-2022
Observation Hemoglobin [Presence] in Urine by Test strip 03-09-2022
Observation Leukocyte esterase [Presence] in Urine by Test strip 03-09-2022
Observation Body Height 03-09-2022 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 03-09-2022 2 {score}
Observation Body Weight 03-09-2022 82.2 kg
Observation Body mass index (BMI) [Ratio] 03-09-2022 27.34 kg/m2
Observation Blood pressure panel with all children optional 03-09-2022
Observation Heart rate 03-09-2022 96 /min
Observation Respiratory rate 03-09-2022 15 /min
Observation Tobacco smoking status 03-09-2022
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 03-09-2022
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 03-09-2022 1 {score}
Procedure Assessment of health and social care needs (procedure) 03-09-2022
Procedure Depression screening (procedure) 03-09-2022
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 03-09-2022
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 03-09-2022
Encounter Encounter for check up (procedure) 06-08-2022
Observation Glucose [Mass/volume] in Serum or Plasma 06-08-2022 71.91 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 06-08-2022 18.89 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 06-08-2022 1.9489 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 06-08-2022 9.11 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 06-08-2022 136.85 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 06-08-2022 4.44 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 06-08-2022 104.95 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 06-08-2022 26.84 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 06-08-2022 56.747 mL/min/{1.73_m2}
Observation Appearance of Urine 06-08-2022
Observation Odor of Urine 06-08-2022
Observation Clarity of Urine 06-08-2022
Observation Color of Urine 06-08-2022
Observation Glucose [Mass/volume] in Urine by Test strip 06-08-2022 2.2579 mg/dL
Observation Glucose [Presence] in Urine by Test strip 06-08-2022
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 06-08-2022 1.3131 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 06-08-2022
Observation Ketones [Mass/volume] in Urine by Test strip 06-08-2022 12.845 mg/dL
Observation Ketones [Presence] in Urine by Test strip 06-08-2022
Observation Specific gravity of Urine by Test strip 06-08-2022 1.0078 {nominal}
Observation pH of Urine by Test strip 06-08-2022 5.1565 pH
Observation Protein [Mass/volume] in Urine by Test strip 06-08-2022 219.45 mg/dL
Observation Protein [Presence] in Urine by Test strip 06-08-2022
Observation Nitrite [Presence] in Urine by Test strip 06-08-2022
Observation Hemoglobin [Presence] in Urine by Test strip 06-08-2022
Observation Leukocyte esterase [Presence] in Urine by Test strip 06-08-2022
Observation Body Height 06-08-2022 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 06-08-2022 2 {score}
Observation Body Weight 06-08-2022 82.2 kg
Observation Body mass index (BMI) [Ratio] 06-08-2022 27.34 kg/m2
Observation Blood pressure panel with all children optional 06-08-2022
Observation Heart rate 06-08-2022 78 /min
Observation Respiratory rate 06-08-2022 14 /min
Observation Tobacco smoking status 06-08-2022
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 06-08-2022
Observation Total score [HARK] 06-08-2022 0 {score}
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 06-08-2022 1 {score}
Observation Total score [AUDIT-C] 06-08-2022 0 {score}
Procedure Assessment of health and social care needs (procedure) 06-08-2022
Procedure Screening for domestic abuse (procedure) 06-08-2022
Procedure Depression screening (procedure) 06-08-2022
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 06-08-2022
Procedure Assessment of substance use (procedure) 06-08-2022
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 06-08-2022
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 06-08-2022
Immunization Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed 06-08-2022
Encounter Encounter for check up (procedure) 07-06-2022
Observation Glucose [Mass/volume] in Serum or Plasma 07-06-2022 93.09 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 07-06-2022 9.56 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 07-06-2022 1.9201 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 07-06-2022 8.75 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 07-06-2022 139.06 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 07-06-2022 4.33 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 07-06-2022 108.41 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 07-06-2022 22.31 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 07-06-2022 34.992 mL/min/{1.73_m2}
Observation Appearance of Urine 07-06-2022
Observation Odor of Urine 07-06-2022
Observation Clarity of Urine 07-06-2022
Observation Color of Urine 07-06-2022
Observation Glucose [Mass/volume] in Urine by Test strip 07-06-2022 1.1955 mg/dL
Observation Glucose [Presence] in Urine by Test strip 07-06-2022
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 07-06-2022 1.4799 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 07-06-2022
Observation Ketones [Mass/volume] in Urine by Test strip 07-06-2022 5.7189 mg/dL
Observation Ketones [Presence] in Urine by Test strip 07-06-2022
Observation Specific gravity of Urine by Test strip 07-06-2022 1.0094 {nominal}
Observation pH of Urine by Test strip 07-06-2022 6.5284 pH
Observation Protein [Mass/volume] in Urine by Test strip 07-06-2022 295.64 mg/dL
Observation Protein [Presence] in Urine by Test strip 07-06-2022
Observation Nitrite [Presence] in Urine by Test strip 07-06-2022
Observation Hemoglobin [Presence] in Urine by Test strip 07-06-2022
Observation Leukocyte esterase [Presence] in Urine by Test strip 07-06-2022
Observation Body Height 07-06-2022 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 07-06-2022 3 {score}
Observation Body Weight 07-06-2022 82.2 kg
Observation Body mass index (BMI) [Ratio] 07-06-2022 27.34 kg/m2
Observation Blood pressure panel with all children optional 07-06-2022
Observation Heart rate 07-06-2022 70 /min
Observation Respiratory rate 07-06-2022 15 /min
Observation Tobacco smoking status 07-06-2022
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 07-06-2022
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 07-06-2022 0 {score}
Observation Fall risk total [Morse Fall Scale] 07-06-2022 101 {#}
Observation Fall risk level [Morse Fall Scale] 07-06-2022
Observation Total score [AUDIT-C] 07-06-2022 1 {score}
Procedure Assessment of health and social care needs (procedure) 07-06-2022
Procedure Assessment of anxiety (procedure) 07-06-2022
Procedure Assessment using Morse Fall Scale (procedure) 07-06-2022
Procedure Assessment of substance use (procedure) 07-06-2022
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 07-06-2022
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 07-06-2022
Encounter Encounter for check up (procedure) 08-03-2022
Observation Glucose [Mass/volume] in Serum or Plasma 08-03-2022 94.14 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 08-03-2022 14.72 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 08-03-2022 2.0865 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 08-03-2022 9.1 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 08-03-2022 138.24 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 08-03-2022 3.74 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 08-03-2022 101.22 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 08-03-2022 25.99 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 08-03-2022 32.688 mL/min/{1.73_m2}
Observation Appearance of Urine 08-03-2022
Observation Odor of Urine 08-03-2022
Observation Clarity of Urine 08-03-2022
Observation Color of Urine 08-03-2022
Observation Glucose [Mass/volume] in Urine by Test strip 08-03-2022 1.0124 mg/dL
Observation Glucose [Presence] in Urine by Test strip 08-03-2022
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 08-03-2022 1.2928 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 08-03-2022
Observation Ketones [Mass/volume] in Urine by Test strip 08-03-2022 3.9035 mg/dL
Observation Ketones [Presence] in Urine by Test strip 08-03-2022
Observation Specific gravity of Urine by Test strip 08-03-2022 1.0313 {nominal}
Observation pH of Urine by Test strip 08-03-2022 5.9503 pH
Observation Protein [Mass/volume] in Urine by Test strip 08-03-2022 268.73 mg/dL
Observation Protein [Presence] in Urine by Test strip 08-03-2022
Observation Nitrite [Presence] in Urine by Test strip 08-03-2022
Observation Hemoglobin [Presence] in Urine by Test strip 08-03-2022
Observation Leukocyte esterase [Presence] in Urine by Test strip 08-03-2022
Observation Body Height 08-03-2022 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 08-03-2022 4 {score}
Observation Body Weight 08-03-2022 82.2 kg
Observation Body mass index (BMI) [Ratio] 08-03-2022 27.34 kg/m2
Observation Blood pressure panel with all children optional 08-03-2022
Observation Heart rate 08-03-2022 63 /min
Observation Respiratory rate 08-03-2022 13 /min
Observation Tobacco smoking status 08-03-2022
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 08-03-2022
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 08-03-2022 0 {score}
Observation Fall risk total [Morse Fall Scale] 08-03-2022 37 {#}
Observation Fall risk level [Morse Fall Scale] 08-03-2022
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 08-03-2022 1 {score}
Observation Total score [AUDIT-C] 08-03-2022 1 {score}
Procedure Medication Reconciliation (procedure) 08-03-2022
Procedure Assessment of health and social care needs (procedure) 08-03-2022
Procedure Assessment of anxiety (procedure) 08-03-2022
Procedure Assessment using Morse Fall Scale (procedure) 08-03-2022
Procedure Depression screening (procedure) 08-03-2022
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 08-03-2022
Procedure Assessment of substance use (procedure) 08-03-2022
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 08-03-2022
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 08-03-2022
Encounter Encounter for check up (procedure) 10-05-2022
Observation Glucose [Mass/volume] in Serum or Plasma 10-05-2022 95.2 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 10-05-2022 16.93 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 10-05-2022 2.0707 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 10-05-2022 8.56 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 10-05-2022 142.39 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 10-05-2022 5.12 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 10-05-2022 110.66 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 10-05-2022 24.19 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 10-05-2022 50.39 mL/min/{1.73_m2}
Observation Appearance of Urine 10-05-2022
Observation Odor of Urine 10-05-2022
Observation Clarity of Urine 10-05-2022
Observation Color of Urine 10-05-2022
Observation Glucose [Mass/volume] in Urine by Test strip 10-05-2022 0.9199 mg/dL
Observation Glucose [Presence] in Urine by Test strip 10-05-2022
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 10-05-2022 1.1283 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 10-05-2022
Observation Ketones [Mass/volume] in Urine by Test strip 10-05-2022 2.5668 mg/dL
Observation Ketones [Presence] in Urine by Test strip 10-05-2022
Observation Specific gravity of Urine by Test strip 10-05-2022 1.0091 {nominal}
Observation pH of Urine by Test strip 10-05-2022 6.665 pH
Observation Protein [Mass/volume] in Urine by Test strip 10-05-2022 352.13 mg/dL
Observation Protein [Presence] in Urine by Test strip 10-05-2022
Observation Nitrite [Presence] in Urine by Test strip 10-05-2022
Observation Hemoglobin [Presence] in Urine by Test strip 10-05-2022
Observation Leukocyte esterase [Presence] in Urine by Test strip 10-05-2022
Observation Body Height 10-05-2022 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 10-05-2022 1 {score}
Observation Body Weight 10-05-2022 82.2 kg
Observation Body mass index (BMI) [Ratio] 10-05-2022 27.34 kg/m2
Observation Blood pressure panel with all children optional 10-05-2022
Observation Heart rate 10-05-2022 82 /min
Observation Respiratory rate 10-05-2022 14 /min
Observation Tobacco smoking status 10-05-2022
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 10-05-2022
Observation Fall risk total [Morse Fall Scale] 10-05-2022 120 {#}
Observation Fall risk level [Morse Fall Scale] 10-05-2022
Observation Total score [DAST-10] 10-05-2022 1 {score}
Procedure Medication Reconciliation (procedure) 10-05-2022
Procedure Assessment of health and social care needs (procedure) 10-05-2022
Procedure Assessment using Morse Fall Scale (procedure) 10-05-2022
Procedure Assessment of substance use (procedure) 10-05-2022
Procedure Screening for drug abuse (procedure) 10-05-2022
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 10-05-2022
Immunization Influenza, seasonal, injectable, preservative free 10-05-2022
Encounter Encounter for check up (procedure) 01-04-2023
Condition Full-time employment (finding) 01-04-2023
Observation Glucose [Mass/volume] in Serum or Plasma 01-04-2023 64.68 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 01-04-2023 12.08 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 01-04-2023 1.9479 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 01-04-2023 9.97 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 01-04-2023 137.91 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 01-04-2023 4.44 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 01-04-2023 109.73 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 01-04-2023 22.11 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 01-04-2023 46.285 mL/min/{1.73_m2}
Observation Appearance of Urine 01-04-2023
Observation Odor of Urine 01-04-2023
Observation Clarity of Urine 01-04-2023
Observation Color of Urine 01-04-2023
Observation Glucose [Mass/volume] in Urine by Test strip 01-04-2023 1.2698 mg/dL
Observation Glucose [Presence] in Urine by Test strip 01-04-2023
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 01-04-2023 0.2612 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 01-04-2023
Observation Ketones [Mass/volume] in Urine by Test strip 01-04-2023 14.784 mg/dL
Observation Ketones [Presence] in Urine by Test strip 01-04-2023
Observation Specific gravity of Urine by Test strip 01-04-2023 1.0018 {nominal}
Observation pH of Urine by Test strip 01-04-2023 5.6952 pH
Observation Protein [Mass/volume] in Urine by Test strip 01-04-2023 306.38 mg/dL
Observation Protein [Presence] in Urine by Test strip 01-04-2023
Observation Nitrite [Presence] in Urine by Test strip 01-04-2023
Observation Hemoglobin [Presence] in Urine by Test strip 01-04-2023
Observation Leukocyte esterase [Presence] in Urine by Test strip 01-04-2023
Observation Body Height 01-04-2023 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 01-04-2023 1 {score}
Observation Body Weight 01-04-2023 82.2 kg
Observation Body mass index (BMI) [Ratio] 01-04-2023 27.34 kg/m2
Observation Blood pressure panel with all children optional 01-04-2023
Observation Heart rate 01-04-2023 65 /min
Observation Respiratory rate 01-04-2023 14 /min
Observation Tobacco smoking status 01-04-2023
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 01-04-2023
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 01-04-2023 2 {score}
Observation Fall risk total [Morse Fall Scale] 01-04-2023 12 {#}
Observation Fall risk level [Morse Fall Scale] 01-04-2023
Observation Total score [AUDIT-C] 01-04-2023 1 {score}
Procedure Medication Reconciliation (procedure) 01-04-2023
Procedure Assessment of health and social care needs (procedure) 01-04-2023
Procedure Assessment of anxiety (procedure) 01-04-2023
Procedure Assessment using Morse Fall Scale (procedure) 01-04-2023
Procedure Assessment of substance use (procedure) 01-04-2023
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 01-04-2023
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 01-04-2023
Encounter General examination of patient (procedure) 03-15-2023
Condition Medication review due (situation) 03-15-2023
Observation Glucose [Mass/volume] in Serum or Plasma 03-15-2023 85.08 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 03-15-2023 16.61 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 03-15-2023 2.0669 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 03-15-2023 8.85 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 03-15-2023 136.34 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 03-15-2023 4.06 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 03-15-2023 105.99 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 03-15-2023 22.28 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 03-15-2023 47.954 mL/min/{1.73_m2}
Observation Appearance of Urine 03-15-2023
Observation Odor of Urine 03-15-2023
Observation Clarity of Urine 03-15-2023
Observation Color of Urine 03-15-2023
Observation Glucose [Mass/volume] in Urine by Test strip 03-15-2023 2.0903 mg/dL
Observation Glucose [Presence] in Urine by Test strip 03-15-2023
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 03-15-2023 1.4447 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 03-15-2023
Observation Ketones [Mass/volume] in Urine by Test strip 03-15-2023 19.202 mg/dL
Observation Ketones [Presence] in Urine by Test strip 03-15-2023
Observation Specific gravity of Urine by Test strip 03-15-2023 1.0218 {nominal}
Observation pH of Urine by Test strip 03-15-2023 5.7025 pH
Observation Protein [Mass/volume] in Urine by Test strip 03-15-2023 215.81 mg/dL
Observation Protein [Presence] in Urine by Test strip 03-15-2023
Observation Nitrite [Presence] in Urine by Test strip 03-15-2023
Observation Hemoglobin [Presence] in Urine by Test strip 03-15-2023
Observation Leukocyte esterase [Presence] in Urine by Test strip 03-15-2023
Observation Body Height 03-15-2023 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 03-15-2023 1 {score}
Observation Body Weight 03-15-2023 82.2 kg
Observation Body mass index (BMI) [Ratio] 03-15-2023 27.34 kg/m2
Observation Blood pressure panel with all children optional 03-15-2023
Observation Heart rate 03-15-2023 98 /min
Observation Respiratory rate 03-15-2023 12 /min
Observation Tobacco smoking status 03-15-2023
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 03-15-2023
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 03-15-2023 5 {score}
Observation Total score [AUDIT-C] 03-15-2023 0 {score}
Procedure Assessment of health and social care needs (procedure) 03-15-2023
Procedure Assessment of anxiety (procedure) 03-15-2023
Procedure Assessment of substance use (procedure) 03-15-2023
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 03-15-2023
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 03-15-2023
Encounter Urgent care clinic (environment) 09-27-2023
Observation Glucose [Mass/volume] in Serum or Plasma 09-27-2023 86.86 mg/dL
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 09-27-2023 11.6 mg/dL
Observation Creatinine [Mass/volume] in Serum or Plasma 09-27-2023 1.9143 mg/dL
Observation Calcium [Mass/volume] in Serum or Plasma 09-27-2023 9.14 mg/dL
Observation Sodium [Moles/volume] in Serum or Plasma 09-27-2023 136.1 mmol/L
Observation Potassium [Moles/volume] in Serum or Plasma 09-27-2023 4.64 mmol/L
Observation Chloride [Moles/volume] in Serum or Plasma 09-27-2023 109.37 mmol/L
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 09-27-2023 28.63 mmol/L
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 09-27-2023 57.116 mL/min/{1.73_m2}
Observation Appearance of Urine 09-27-2023
Observation Odor of Urine 09-27-2023
Observation Clarity of Urine 09-27-2023
Observation Color of Urine 09-27-2023
Observation Glucose [Mass/volume] in Urine by Test strip 09-27-2023 2.3941 mg/dL
Observation Glucose [Presence] in Urine by Test strip 09-27-2023
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 09-27-2023 0.9377 mg/dL
Observation Bilirubin.total [Presence] in Urine by Test strip 09-27-2023
Observation Ketones [Mass/volume] in Urine by Test strip 09-27-2023 12.062 mg/dL
Observation Ketones [Presence] in Urine by Test strip 09-27-2023
Observation Specific gravity of Urine by Test strip 09-27-2023 1.0352 {nominal}
Observation pH of Urine by Test strip 09-27-2023 5.6108 pH
Observation Protein [Mass/volume] in Urine by Test strip 09-27-2023 355.23 mg/dL
Observation Protein [Presence] in Urine by Test strip 09-27-2023
Observation Nitrite [Presence] in Urine by Test strip 09-27-2023
Observation Hemoglobin [Presence] in Urine by Test strip 09-27-2023
Observation Leukocyte esterase [Presence] in Urine by Test strip 09-27-2023
Observation Body Height 09-27-2023 173.4 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 09-27-2023 3 {score}
Observation Body Weight 09-27-2023 82.2 kg
Observation Body mass index (BMI) [Ratio] 09-27-2023 27.34 kg/m2
Observation Blood pressure panel with all children optional 09-27-2023
Observation Heart rate 09-27-2023 91 /min
Observation Respiratory rate 09-27-2023 14 /min
Observation Tobacco smoking status 09-27-2023
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 09-27-2023
Observation Fall risk total [Morse Fall Scale] 09-27-2023 21 {#}
Observation Fall risk level [Morse Fall Scale] 09-27-2023
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 09-27-2023 2 {score}
Observation Total score [DAST-10] 09-27-2023 1 {score}
Procedure Assessment of health and social care needs (procedure) 09-27-2023
Procedure Assessment using Morse Fall Scale (procedure) 09-27-2023
Procedure Depression screening (procedure) 09-27-2023
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 09-27-2023
Procedure Assessment of substance use (procedure) 09-27-2023
Procedure Screening for drug abuse (procedure) 09-27-2023
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 09-27-2023
Encounter Emergency room admission (procedure) 10-31-2023
Condition Sprain (morphologic abnormality) 10-31-2023
Condition Sprain of ankle 10-31-2023
MedicationRequest Acetaminophen 325 MG Oral Tablet 10-31-2023
